Anhydrous cosmetic compositions containing resveratrol derivatives

Information

  • Patent Grant
  • 8344024
  • Patent Number
    8,344,024
  • Date Filed
    Tuesday, May 27, 2008
    16 years ago
  • Date Issued
    Tuesday, January 1, 2013
    11 years ago
Abstract
An anhydrous color cosmetic composition comprising at least one resveratrol derivative and particulates; and an anhydrous emulsion skin care composition.
Description
TECHNICAL FIELD

The invention is in the field of anhydrous cosmetic compositions for application to keratinous surfaces such as skin, hair, or nails, for purposes of coloring or treating the surface.


BACKGROUND OF THE INVENTION

Resveratrol, also referred to as 3,5,4′-trihydroxystilbene, is a polyhydroxy-substituted compound having the general formula:




embedded image


It is present in red grapes, raspberries, blueberries, and certain other plant berries or extracts. It has been reported that resveratrol has anti-aging, anti-cancer, and antiviral effects. Because of its perceived fountain-of-youth properties, resveratrol has been incorporated into a variety of cosmetic formulations, such as skin creams. However, one problem with resveratrol is that it is generally unstable in cosmetic formulations. Accordingly, if used in cosmetic formulas, it can only be used in very small amounts. If present in too large an amount, the resveratrol will hydrolyze and cause the cosmetic formulation into which it is incorporated to become discolored.


One way to address the instability of resveratrol is to derivatize the resveratrol by substituting the hydroxy groups at the 3, 5, and 4′ position with other functional groups to form resveratrol derivatives that are more stable in cosmetic formulas. It has been discovered that resveratrol derivatives of inorganic acids, organic carboxylic acids, mono-, -di, or polysaccharides, or other functional groups are more stable in cosmetic formulations, particularly those in the emulsion form.


It is an object of the invention to provide anhydrous cosmetic compositions containing at least one resveratrol derivative.


It is a further object of the invention to provide an anhydrous cosmetic composition containing at least one resveratrol derivative in an anhydrous emulsion form.


It is a further object of the invention to provide anhydrous color cosmetics that are aesthically pleasing and stable compositions that are commercially acceptable, that is, suitable for use by and sale to discriminating consumers that have high standards.


It is a further object of the invention to provide anhydrous cosmetic compositions in the form of liquids, solids, or semi-solids, or anhydrous emulsions, containing at least one resveratrol derivative.


SUMMARY OF THE INVENTION

The invention is directed to an anhydrous cosmetic composition comprising at least one resveratrol derivative.


The invention is further directed to an anhydrous emulsion cosmetic composition comprising at least one resveratrol derivative.







DETAILED DESCRIPTION

The compositions of the invention may be in the liquid, solid, or semi-solid form. The compositions may also be in the form of non-aqueous, or anhydrous, emulsions. Anhydrous emulsions are formed when the resveratrol derivative is solubilized or dispersed in a polar non-aqueous solvent such as ethanol, propylene glycol, butylene glycol, and the like. The compositions of the invention may be in the form of lipsticks, blush, eyeshadow, mascara, eyeliner, lipliner, nail color, skin treatment serums or gels, and the like.


I. Resveratrol Derivatives


Without being bound by this explanation, it is believed that the practical use of resveratrol in cosmetic compositions has been limited by instability due to the phenol groups. The resveratrol derivatives used in the compositions of the invention contain protective groups, which function to stabilize the phenol groups of resveratrol and make the resveratrol derivative suitable for use in emulsions where superior aesthetics and stability are required for commercially acceptable products. In addition, once the compositions containing the derivative is applied to skin, the protective groups can be easily hydrolyzed from the molecule, preferably by enzymes and other ingredients on the skin surface, to release an active form of resveratrol into the skin.


The resveratrol derivatives of the present invention have a general formula of:




embedded image


wherein X, Y, and Z are either hydrogen or a protective group, provided that at least one of X, Y, and Z is the protective group.


The resveratrol derivatives may be present ranging from about 0.001 to 95%, preferably from about 0.005 to 90%, more preferably from about 0.1 to 20% by weight of the total composition.


A. Resveratrol Esters of Inorganic or Organic Acids


Resveratrol esters of inorganic acids, in which one or more of the X, Y, and Z are inorganic acid functional groups such as phosphates, nitrates, sulfonates, and carbonates, can be used in the present invention. Following is a list of exemplary inorganic acid esters that are particularly suitable for practice of the present invention:


3-phosphate-5,4′-dihydroxystilbene;


5-phosphate-3,4′-dihydroxystilbene;


4′-phosphate-3,5-dihydroxystilbene;


3,5-diphosphate-4′-hydroxystilbene;


3,4′-diphosphate-5-hydroxystilbene;


4′,5-diphosphate-3-hydroxystilbene;


3,5,4′-triphosphate stilbene;


3-nitrate-5,4′-dihydroxystilbene;


5-nitrate-3,4′-dihydroxystilbene;


4′-nitrate-3,5-dihydroxystilbene;


3,5-dinitrate-4′-hydroxystilbene;


3,4′-dinitrate-5-hydroxystilbene;


4′,5-dinitrate-3-hydroxystilbene;


3,5,4′-trinitrate stilbene;


3-sulfonate-5,4′-dihydroxystilbene;


5-sulfonate-3,4′-dihydroxystilbene;


4′-sulfonate-3,5-dihydroxystilbene;


3,5-disulfonate-4′-hydroxystilbene;


3,4′-disulfonate-5-hydroxystilbene;


4′,5-disulfonate-3-hydroxystilbene;


3,5,4′-trisulfonate stilbene;


3-carbonate-5,4′-dihydroxystilbene;


5-carbonate-3,4′-dihydroxystilbene;


4′-carbonate-3,5-dihydroxystilbene;


3,5-dicarbonate-4′-hydroxystilbene;


3,4′-dicarbonate-5-hydroxystilbene;


4′,5-dicarbonate-3-hydroxystilbene; and


3,5,4′-tricarbonate stilbene.


Pharmaceutically acceptable salts of the above-listed resveratrol esters can also be used in the cosmetic compositions of the present invention. Such salts may include one or more monovalent or divalent cations selected from the group consisting of Na, K, Mg, Ca, Fe, and NH4. The salts can be formed by adding corresponding bases, such as sodium hydroxide, potassium hydroxide, and the like, into a solution containing the resveratrol esters.


Such inorganic acid esters of resveratrol may be readily formed by well known chemical processes that substitute the hydroxyl groups of phenols or polyphenols with the phosphate, sulfonates, and carbonate functional groups. For example, U.S. Pat. No. 4,003,966 describes a one-step process for selectively phosphorylating phenols to form phosphate esters thereof, the contents of which are incorporated herein by reference in their entireties for all purposes.


Preferred is the 3,4′,5-triphosphate stilbene, also referred to as a resveratrol triphosphate ester having the formula (resveratrol triphosphate):




embedded image


Phosphate esters of resveratrol, including resveratrol triphosphate, are disclosed in International Patent Application Publication No. WO 2006/029484A1, which is hereby incorporated by reference in its entirety. Resveratrol triphosphate may be synthesized by the method as set forth in Example 2 of WO 2006/029484A1. More specifically, a solution of resveratrol (3,4,5-trihydroxystilbene) (25 mmols, 5.7 grams) and dimethylaminopyridine (7.5 mmols, 0.93 grams) in 100 ml acetonitrile is cooled under nitrogen up to −10° C. After 10 minutes, carbon tetrachloride (375 mmol, 36.2 ml) and DIEA (159 mmol; 27.7 ml) and the mixture maintained under stirring for 30 minutes. Dibenzylphosphate (113 mmols, 25.0 ml) is added and the mixture stirred for an additional 12 hours at room temperature. The course of the reaction is monitored by TLC (silica F254, eluent ethyl acetate/n-hexane 80/20 v/v). One liter of 0.5 M KH2PO4 is added, and the mixture then extract with ethyl acetate. The resulting product, tri(dibenzylphosphate) resveratrol, is purified by filtration on a silica gel, washing first with a mixture of ethyl acetate/n-hexane (80/20 v/v) to remove any remaining unreacted resveratrol, and then with methanol, to obtain a yellow oil.


To the tri(dibenzylphosphate) resveratrol (12.5 mmol) in 200 mL of anhydrous DCM at 0° C., is added bromomethylsilane (79 mmols, 10.4 mL). After 2 hours, 300 mL of H2O is added, and the reaction mixture is stirred for 1 hour. The water phase is washed again with ethyl acetate, then lyophilized to obtain an orange oil.


To the product obtained above, solubilized in 400 mL of ethanol, is added CH3ONa (37 mmol; 2.03 g) and the reaction stirred for 12 hours at room temperature. The ethanol is evaporated in a rotavapor, and the residue solubilized in H2O. The water phase is washed with ethyl acetate and lyophilized. The mass spectrum of the resulting white solid shows the presence of resveratrol triphosphate (PM=468.1), with a total yield of >90% with respect to resveratrol.


If desired the resveratrol triphosphate may be neutralized with organic or inorganic bases such as sodium hydroxide, potassium hydroxide and the like. Particularly preferred is where the resveratrol triphosphate is neutralized with sodium hydroxide to form trisodium resveratrol triphosphate.


B. Carboxylic Acid Esters of Resveratrol


Another group of resveratrol derivatives that can be used in the present invention is esters of resveratrol and carboxylic acids, in which one or more of X, Y, and Z is a —C(O)—R1 group, wherein R1 is selected from the group consisting of linear, branched or cyclic C1-C40 alkyl, substituted C1-C40 alkyl, C1-C40 alkenyl, substituted C1-C40 alkenyl, C1-C40 alkynyl, substituted C1-C40 alkynyl, C1-C40 aryl, and C1-C40 substituted aryl. In one preferred embodiment, the R group is a straight or branched chain fatty, or C6-30, saturated or unsaturated alkyl group.


Exemplary carboxylic acids that can be used to form ester of resveratrol include, but are not limited to: substituted or unsubstituted saturated monocarboxylic acids, such as acetic acid, propionic acid, butyric acid (C4), valeric acid, hexanoic acid, caprylic acid (C8), lauric acid, stearic acid (C18), isostearic acid (branched C18), linoleic acid, linolenic acid, myristic acid (C14), arachidic acid (C20), arichidonic acid, erucic acid, behenic acid (C22), lauric acid (C12), capric acid (C10), caproic (C6), and palmitic acid (C16); or carboxylic acids substituted with cyclic disulfide groups, e.g. lipoic acid; or unsaturated monocarboxylic acids, such as acrylic acid, methacrylic acid, sorbic acid, oleic acid, linoleic acid, linolenic acid, docosahexaenoic acid, and eicosapentaenoic acid; amino acids, such as arginine, glutamine, and tyrosine; keto acids, such as pyruvic acid and acetoacetic acid; aromatic carboxylic acids, such as ascorbic acid, benzoic acid, salicylic acid, and ferulic acid; di- and tri-carboxylic acids, such as oxalic acid, malonic acid, malic acid, succinic acid, and glutaric acid. Also suitable are esters of carboxylic acids having cyclic disulfide substitutions, for example lipoic acid. The designation “C” followed by a number indicates the number of carbon atoms in the alkyl chain.


Following is a list of exemplary carboxylic acid esters of resveratrol that are particularly suitable for practice of the present invention:


3-acetate-5,4′-dihydroxystilbene;


5-acetate-3,4′-dihydroxystilbene;


4′-acetate-3,5-dihydroxystilbene;


3,5-diacetate-4′-hydroxystilbene;


3,4′-diacetate-5-hydroxystilbene;


4′,5-diacetate-3-hydroxystilbene;


3,5,4′-triacetate stilbene;


3-propionate-5,4′-dihydroxystilbene;


5-propionate-3,4′-dihydroxystilbene;


4′-propionate-3,5-dihydroxystilbene;


3,5-dipropionate-4′-hydroxystilbene;


3,4′-dipropionate-5-hydroxystilbene;


4′,5-dipropionate-3-hydroxystilbene;


3,5,4′-tripropionate stilbene;


3-butyrate-5,4′-dihydroxystilbene;


5-butyrate-3,4′-dihydroxystilbene;


4′-butyrate-3,5-dihydroxystilbene;


3,5-dibutyrate-4′-hydroxystilbene;


3,4′-dibutyrate-5-hydroxystilbene;


4′,5-dibutyrate-3-hydroxystilbene;


3,5,4′-tributyrate stilbene;


3-valerate-5,4′-dihydroxystilbene;


5-valerate-3,4′-dihydroxystilbene;


4′-valerate-3,5-dihydroxystilbene;


3,5-divalerate-4′-hydroxystilbene;


3,4′-divalerate-5-hydroxystilbene;


4′,5-divalerate-3-hydroxystilbene;


3,5,4′-trivalerate stilbene;


3-hexanoate-5,4′-dihydroxystilbene;


5-hexanoate -3,4′-dihydroxystilbene;


4′-hexanoate-3,5-dihydroxystilbene;


3,5-dihexanoate-4′-hydroxystilbene;


3,4′-dihexanoate-5-hydroxystilbene;


4′,5-dihexanoate-3-hydroxystilbene;


3,5,4′-trihexanoate stilbene;


3-caprylate-5,4′-dihydroxystilbene;


5-caprylate-3,4′-dihydroxystilbene;


4′-caprylate-3,5-dihydroxystilbene;


3,5-dicaprylate-4′-hydroxystilbene;


3,4′-dicaprylate-5-hydroxystilbene;


4′,5-dicaprylate-3-hydroxystilbene;


3,5,4′-tricaprylate stilbene;


3-laurate-5,4′-dihydroxystilbene;


5-laurate-3,4′-dihydroxystilbene;


4′-laurate-3,5-dihydroxystilbene;


3,5-dilaurate-4′-hydroxystilbene;


3,4′-dilaurate-5-hydroxystilbene;


4′,5-dilaurate-3-hydroxystilbene;


3,5,4′-trilaurate stilbene;


3-stearate-5,4′-dihydroxystilbene;


5-stearate-3,4′-dihydroxystilbene;


4′-stearate-3,5-dihydroxystilbene;


3,5-distearate-4′-hydroxystilbene;


3,4′-distearate-5-hydroxystilbene;


4′,5-distearate-3-hydroxystilbene;


3,5,4′-tristearate stilbene;


3-palmitate-5,4′-dihydroxystilbene;


5-palmitate-3,4′-dihydroxystilbene;


4′-palmitate-3,5-dihydroxystilbene;


3,5-dipalmitate-4′-hydroxystilbene;


3,4′-dipalmitate-5-hydroxystilbene;


4′,5-dipalmitate-3-hydroxystilbene;


3,5,4′-tripalmitate stilbene;


3-acrylate-5,4′-dihydroxystilbene;


5-acrylate-3,4′-dihydroxystilbene;


4′-acrylate-3,5-dihydroxystilbene;


3,5-diacrylate-4′-hydroxystilbene;


3,4′-diacrylate-5-hydroxystilbene;


4′,5-diacrylate-3-hydroxystilbene;


3,5,4′-triacrylate stilbene;


3-methacrylate-5,4′-dihydroxystilbene;


5-methacrylate-3,4′-dihydroxystilbene;


4′-methacrylate-3,5-dihydroxystilbene;


3,5-dimethacrylate-4′-hydroxystilbene;


3,4′-dimethacrylate-5-hydroxystilbene;


4′,5-dimethacrylate-3-hydroxystilbene;


3,5,4′-trimethacrylate stilbene;


3-sorbate-5,4′-dihydroxystilbene;


5-sorbate-3,4′-dihydroxystilbene;


4′-sorbate-3,5-dihydroxystilbene;


3,5-disorbate-4′-hydroxystilbene;


3,4′-disorbate-5-hydroxystilbene;


4′,5-disorbate-3-hydroxystilbene;


3,5,4′-trisorbate stilbene;


3-oleate-5,4′-dihydroxystilbene;


5-oleate-3,4′-dihydroxystilbene;


4′-oleate-3,5-dihydroxystilbene;


3,5-dioleate-4′-hydroxystilbene;


3,4′-dioleate-5-hydroxystilbene;


4′,5-dioleate-3-hydroxystilbene;


3,5,4′-trioleate stilbene;


3-linoleate-5,4′-dihydroxystilbene;


5-linoleate-3,4′-dihydroxystilbene;


4′-linoleate-3,5-dihydroxystilbene;


3,5-dilinoleate-4′-hydroxystilbene;


3,4′-dilinoleate-5-hydroxystilbene;


4′,5-dilinoleate-3-hydroxystilbene;


3,5,4′-trilinoleate stilbene;


3-linolenate-5,4′-dihydroxystilbene;


5-linolenate-3,4′-dihydroxystilbene;


4′-linolenate-3,5-dihydroxystilbene;


3,5-dilinolenate-4′-hydroxystilbene;


3,4′-dilinolenate-5-hydroxystilbene;


4′,5-dilinolenate-3-hydroxystilbene;


3,5,4′-trilinolenate stilbene;


3-docosahexaenoate-5,4′-dihydroxystilbene;


5-docosahexaenoate-3,4′-dihydroxystilbene;


4′-docosahexaenoate-3,5-dihydroxystilbene;


3,5-didocosahexaenoate-4′-hydroxystilbene;


3,4′-didocosahexaenoate-5-hydroxystilbene;


4′,5-didocosahexaenoate-3-hydroxystilbene;


3,5,4′-tridocosahexaenoate stilbene;


3-eicosapentaenoic-5,4′-dihydroxystilbene;


5-eicosapentaenoic-3,4′-dihydroxystilbene;


4′-eicosapentaenoic-3,5-dihydroxystilbene;


3,5-dieicosapentaenoic-4′-hydroxystilbene;


3,4′-dieicosapentaenoic-5-hydroxystilbene;


4′,5-dieicosapentaenoic-3-hydroxystilbene;


3,5,4′-trieicosapentaenoic stilbene;


3-arginate-5,4′-dihydroxystilbene;


5-arginate-3,4′-dihydroxystilbene;


4′-arginate-3,5-dihydroxystilbene;


3,5-diarginate-4′-hydroxystilbene;


3,4′-diarginate-5-hydroxystilbene;


4′,5-diarginate-3-hydroxystilbene;


3,5,4′-triarginate stilbene;


3-glutamate-5,4′-dihydroxystilbene;


5-glutamate-3,4′-dihydroxystilbene;


4′-glutamate-3,5-dihydroxystilbene;


3,5-diglutamate-4′-hydroxystilbene;


3,4′-diglutamate-5-hydroxystilbene;


4′,5-diglutamate-3-hydroxystilbene;


3,5,4′-triglutamate stilbene;


3-tyrosate-5,4′-dihydroxystilbene;


5-tyrosate-3,4′-dihydroxystilbene;


4′-tyrosate-3,5-dihydroxystilbene;


3,5-dityrosate-4′-hydroxystilbene;


3,4′-dityrosate-5-hydroxystilbene;


4′,5-dityrosate-3-hydroxystilbene;


3,5,4′-trityrosate stilbene;


3-pyruvate-5,4′-dihydroxystilbene;


5-pyruvate-3,4′-dihydroxystilbene;


4′-pyruvate-3,5-dihydroxystilbene;


3,5-dipyruvate-4′-hydroxystilbene;


3,4′-dipyruvate-5-hydroxystilbene;


4′,5-dipyruvate-3-hydroxystilbene;


3,5,4′-tripyruvate stilbene;


3-acetoacetate-5,4′-dihydroxystilbene;


5-acetoacetate-3,4′-dihydroxystilbene;


4′-acetoacetate-3,5-dihydroxystilbene;


3,5-diacetoacetate-4′-hydroxystilbene;


3,4′-diacetoacetate-5-hydroxystilbene;


4′,5-diacetoacetate-3-hydroxystilbene;


3,5,4′-triacetoacetate stilbene;


3-ascorbate-5,4′-dihydroxystilbene;


5-ascorbate-3,4′-dihydroxystilbene;


4′-ascorbate-3,5-dihydroxystilbene;


3,5-diascorbate-4′-hydroxystilbene;


3,4′-diascorbate-5-hydroxystilbene;


4′,5-diascorbate-3-hydroxystilbene;


3,5,4′-triascorbate stilbene;


3-benzoate-5,4′-dihydroxystilbene;


5-benzoate-3,4′-dihydroxystilbene;


4′-benzoate-3,5-dihydroxystilbene;


3,5-dibenzoate-4′-hydroxystilbene;


3,4′-dibenzoate-5-hydroxystilbene;


4′,5-dibenzoate-3-hydroxystilbene;


3,5,4′-tribenzoate stilbene;


3-salicylate-5,4′-dihydroxystilbene;


5-salicylate-3,4′-dihydroxystilbene;


4′-salicylate-3,5-dihydroxystilbene;


3,5-disalicylate-4′-hydroxystilbene;


3,4′-disalicylate-5-hydroxystilbene;


4′,5-disalicylate-3-hydroxystilbene;


3,5,4′-trisalicylate stilbene;


3-ferulate-5,4′-dihydroxystilbene;


5-ferulate-3,4′-dihydroxystilbene;


4′-ferulate-3,5-dihydroxystilbene;


3,5-diferulate-4′-hydroxystilbene;


3,4′-diferulate-5-hydroxystilbene;


4′,5-diferulate-3-hydroxystilbene;


3,5,4′-triferulate stilbene;


3-oxalate-5,4′-dihydroxystilbene;


5-oxalate-3,4′-dihydroxystilbene;


4′-oxalate-3,5-dihydroxystilbene;


3,5-dioxalate-4′-hydroxystilbene;


3,4′-dioxalate-5-hydroxystilbene;


4′,5-dioxalate-3-hydroxystilbene;


3,5,4′-trioxalate stilbene;


3-malonate-5,4′-dihydroxystilbene;


5-malonate-3,4′-dihydroxystilbene;


4′-malonate-3,5-dihydroxystilbene;


3,5-dimalonate-4′-hydroxystilbene;


3,4′-dimalonate-5-hydroxystilbene;


4′,5-dimalonate-3-hydroxystilbene;


3,5,4′-trimalonate stilbene;


3-malate-5,4′-dihydroxystilbene;


5-malate-3,4′-dihydroxystilbene;


4′-malate-3,5-dihydroxystilbene;


3,5-dimalate-4′-hydroxystilbene;


3,4′-dimalate-5-hydroxystilbene;


4′,5-dimalate-3-hydroxystilbene;


3,5,4′-trimalate stilbene;


3-succinate-5,4′-dihydroxystilbene;


5-succinate-3,4′-dihydroxystilbene;


4′-succinate-3,5-dihydroxystilbene;


3,5-disuccinate-4′-hydroxystilbene;


3,4′-disuccinate-5-hydroxystilbene;


4′,5-disuccinate-3-hydroxystilbene;


3,5,4′-trisuccinate stilbene;


3-glutarate-5,4′-dihydroxystilbene;


5-glutarate-3,4′-dihydroxystilbene;


4′-glutarate-3,5-dihydroxystilbene;


3,5-diglutarate-4′-hydroxystilbene;


3,4′-diglutarate-5-hydroxystilbene;


4′,5-diglutarate-3-hydroxystilbene;


3,5,4′-triglutarate stilbene;


3-glutarate-5,4′-dihydroxystilbene;


5-glutarate-3,4′-dihydroxystilbene;


4′-glutarate-3,5-dihydroxystilbene;


3,5-diglutarate-4′-hydroxystilbene;


3,4′-diglutarate-5-hydroxystilbene;


4′,5-diglutarate-3-hydroxystilbene; and


3,5,4′-triglutarate stilbene;


One particularly preferred group of carboxylic acid esters of resveratrol are either saturated or unsaturated fatty acid esters of resveratrol, such as resveratrol butyrates, resveratrol lipoates, resveratrol valerates, resveratrol hexanoates, resveratrol sorbates, resveratraol laurates, resveratrol stearates, resveratrol palmitates, resveratrol oleates, resveratrol linoleates, resveratrol palmitates, resveratrol stearates, resveratrol lipoate, resveratrol isostearates, resveratrol linolenates, resveratrol eicosapentaenoates, and resveratrol docosahexanoates. Such fatty acid esters of resveratrol can be readily formed by esterification of resveratrol with acid derivaties according to the Schotten-Baumann reaction in alkaline aqueous medium, as described by U.S. Pat. No. 6,572,882, the content of which is incorporated herein by reference in its entireties for all purposes.


Another particularly preferred group of carboxylic acid esters of resveratrol are the aromatic carboxylic acid esters of resveratrol, such as resveratrol ferulates, which can be formed by simply combining ferulic acid with resveratrol in an aqueous medium. In this case the resveratrol ferulates may be mono-, di-, or triferulates; that is where one, two, or three of the hydroxyl groups on the resveratrol are reacted with ferulic acid.


C. Resveratrol Ether Derivatives


Yet another group of resveratrol derivatives that can be used in the present invention are resveratrol ethers, in which one or more of X, Y, and Z is —R2, wherein R2 is selected from the group consisting of linear, branched or cyclic C1-C40 alkyl, substituted C1-C40 alkyl, C1-C40 alkenyl, substituted C1-C40 alkenyl, C1-C40 alkynyl, substituted C1-C40 alkynyl, C1-C40 aryl, substituted C1-C40 aryl, and mono-, di-, oligo-, and polysaccharides. Following is a list of exemplary resveratrol ethers that are particularly suitable for practice of the present invention:


3-methoxy-5,4′-dihydroxystilbene;


5-methoxy-3,4′-dihydroxystilbene;


4′-methoxy-3,5-dihydroxystilbene;


3,5-dimethoxy-4′-hydroxystilbene;


3,4′-dimethoxy-5-hydroxystilbene;


4′,5-dimethoxy-3-hydroxystilbene;


3,5,4′-trimethoxy stilbene;


3-ethoxy-5,4′-dihydroxystilbene;


5-ethoxy-3,4′-dihydroxystilbene;


4′-ethoxy-3,5-dihydroxystilbene;


3,5-diethoxy-4′-hydroxystilbene;


3,4′-diethoxy-5-hydroxystilbene;


4′,5-diethoxy-3-hydroxystilbene;


3,5,4′-triethoxy stilbene;


3-propyloxy-5,4′-dihydroxystilbene;


5-propyloxy-3,4′-dihydroxystilbene;


4′-propyloxy-3,5-dihydroxystilbene;


3,5-dipropyloxy-4′-hydroxystilbene;


3,4′-dipropyloxy-5-hydroxystilbene;


4′,5-dipropyloxy-3-hydroxystilbene;


3,5,4′-tripropyloxy stilbene;


3-phenyloxy-5,4′-dihydroxystilbene;


5-phenyloxy-3,4′-dihydroxystilbene;


4′-phenyloxy-3,5-dihydroxystilbene;


3,5-diphenyloxy-4′-hydroxystilbene;


3,4′-diphenyloxy-5-hydroxystilbene;


4′,5-diphenyloxy-3-hydroxystilbene;


3,5,4′-triphenyloxy stilbene;


3-glucoside-5,4′-dihydroxystilbene;


5-glucoside-3,4′-dihydroxystilbene;


4′-glucoside-3,5-dihydroxystilbene;


3,5-diglucoside-4′-hydroxystilbene;


3,4′-diglucoside-5-hydroxystilbene;


4′,5-diglucoside-3-hydroxystilbene; and


3,5,4′-triglucoside stilbene.


In one specific embodiment of the present invention, a methoxy-substituted resveratrol derivative is used. For example, the compositions of the present invention may comprise 3,5-dimethoxy-4′-hydroxystilbene, which can be extracted from the Indian Kino Tree (Pterocarpus marsupium) and is commercially available under the trade name “Pterostilbene” from Sigma-Aldrich at St. Louis, Mo.


In another specific embodiment of the present invention, the resveratrol derivative contains one or more saccharide-containing protective groups, such as glucose, galactose, mannose, fructose, sucrose, lactose, maltose, trehalose, and the like. For example, resveratrol glucoside, which can be obtained by extraction from plants or plant material such as polygonum cuspidatum tissue or in vitro cultures of vitis vinifera cells, is used in the cosmetic compositions of the present invention.


D. Nitrogen-Containing Derivatives of Resveratrol


The resveratrol derivatives used in the compositions of the present invention may also contain one or more nitrogen-containing functional groups, i.e., one or more of X,Y, and Z in the above formula are selected from the group consisting of amides, amines, imines, amidines, and carboxamidines. Following is a list of exemplary resveratrol ethers that are particularly suitable for practice of the present invention:


3-amide-5,4′-dihydroxystilbene;


5-amide-3,4′-dihydroxystilbene;


4′-amide-3,5-dihydroxystilbene;


3,5-diamide-4′-hydroxystilbene;


3,4′-diamide-5-hydroxystilbene;


4′,5-diamide-3-hydroxystilbene;


3,5,4′-triamide stilbene;


3-amino-5,4′-dihydroxystilbene;


5-amino-3,4′-dihydroxystilbene;


4′-amino-3,5-dihydroxystilbene;


3,5-diamino-4′-hydroxystilbene;


3,4′-diamino-5-hydroxystilbene;


4′,5-diamino-3-hydroxystilbene;


3,5,4′-triamino stilbene;


3-imino-5,4′-dihydroxystilbene;


5-imino-3,4′-dihydroxystilbene;


4′-imino-3,5-dihydroxystilbene;


3,5-diimino-4′-hydroxystilbene;


3,4′-diimino-5-hydroxystilbene;


4′,5-diimino-3-hydroxystilbene;


3,5,4′-triimino stilbene;


3-amidino-5,4′-dihydroxystilbene;


5-amidino-3,4′-dihydroxystilbene;


4′-amidino-3,5-dihydroxystilbene;


3,5-diamidino-4′-hydroxystilbene;


3,4′-diamidino-5-hydroxystilbene;


4′,5-diamidino-3-hydroxystilbene; and


3,5,4′-triamidino stilbene.


The compositions of the invention may comprise one, or more than one, resveratrol derivative.


II. Liquid Phase


Preferably, resveratrol derivative used in the compositions of the invention are solubilized or dispersed in a liquid phase. The term “liquid phase” means an ingredient or combination of ingredients that are pourable at room temperature and are suitable for solubilizing or dispersing the resveratrol derivative. Preferably, the compositions of the invention comprise from about about 0.001 to 95%, more preferably from about 0.005 to 90%, more preferably from about 0.1 to 85% by weight of the total composition of a liquid phase.


A. Non-Aqueous Polar Solvents


In the case where the composition is in the form of an anhydrous emulsion, the resveratrol derivative may be solubilized or dispersed in a liquid phase that comprises at least one nonaqueous polar solvent. Suitable nonaqueous polar solvents may include ingredients that are often also referred to as humectants. Examples of suitable nonaqueous polar solvents include mono-, di-, or polyhydric alcohols having from about 2 to 12 carbon atoms. Also suitable are glycols, sugars, and the like. Suitable glycols are in monomeric or polymeric form and include polyethylene and polypropylene glycols such as PEG 4-200, which are polyethylene glycols having from 4 to 200 repeating ethylene oxide units; as well as C1-6 alkylene glycols such as propylene glycol, butylene glycol, pentylene glycol, hexanediol, and the like. Suitable sugars, some of which are also polyhydric alcohols, are also suitable humectants. Examples of such sugars include glucose, fructose, honey, hydrogenated honey, inositol, maltose, mannitol, maltitol, sorbitol, sucrose, xylitol, xylose, and so on. Preferably the nonaqueous polar solvent used to prepare the anhydrous emulsion is a C1-6, preferably C2-4 alkylene glycols, most particularly ethylene, propylene, or butylene glycol.


B. Oils


The liquid phase may comprise one or more oils suitable for solubilizing or dispersing the resveratrol derivative. Suitable oils include silicones, esters, vegetable oils, synthetic oils, including but not limited to those set forth herein. The oils may be volatile or nonvolatile, and are in the form of a pourable liquid at room temperature. The term “volatile” means that the oil has a measurable vapor pressure, or a vapor pressure of at least about 2 mm. of mercury at 20° C. The term “nonvolatile” means that the oil has a vapor pressure of less than about 2 mm. of mercury at 20° C. If present, oils may range from about 0.1 to 95%, preferably from about 0.5 to 85%, more preferably from about 0.5 to 85% by weight of the total composition.


1. Volatile Oils


(a). Volatile Silicones


Suitable volatile oils generally have a viscosity ranging from about 0.5 to 5 centistokes 25° C. and include linear silicones, cyclic silicones, paraffinic hydrocarbons, or mixtures thereof.


Cyclic silicones are of the general formula:




embedded image



where n=3-6.


Linear volatile silicones in accordance with the invention have the general formula:

(CH3)3Si—O—[Si(CH3)2—O]n—Si(CH3)3

where n=0, 1, 2, 3, 4, or 5, preferably 0, 1, 2, 3, or 4.


Linear and cyclic volatile silicones are available from various commercial sources including Dow Corning Corporation and General Electric. The Dow Corning volatile silicones are sold under the tradenames Dow Corning 244, 245, 344, and 200 fluids. These fluids comprise octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane and the like. Also suitable are linear volatile silicones such as hexamethyldisiloxane (viscosity 0.65 centistokes (abbreviated cst)), octamethyltrisiloxane (1.0 cst), decamethyltetrasiloxane (1.5 cst), dodecamethylpentasiloxane (2 cst) and mixtures thereof.


(b). Volatile Paraffinic Hydrocarbons


Also suitable as the volatile oils are various straight or branched chain paraffinic hydrocarbons having 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20 carbon atoms, more preferably 8 to 16 carbon atoms. Suitable hydrocarbons include pentane, hexane, heptane, decane, dodecane, tetradecane, tridecane, and C8-20 isoparaffins as disclosed in U.S. Pat. Nos. 3,439,088 and 3,818,105, both of which are hereby incorporated by reference.


Preferred volatile paraffinic hydrocarbons have a molecular weight of 70-225, preferably 160 to 190 and a boiling point range of 30 to 320, preferably 60 to 260° C., and a viscosity of less than about 10 cst. at 25° C. Such paraffinic hydrocarbons are available from EXXON under the ISOPARS trademark, and from the Permethyl Corporation. Suitable C12 isoparaffins are manufactured by Permethyl Corporation under the tradename Permethyl 99A. Various C16 isoparaffins commercially available, such as isohexadecane (having the tradename Permethyl R), are also suitable.


2. Non-Volatile Oils


A variety of nonvolatile oils are also suitable for use in the cosmetic compositions of the invention. The nonvolatile oils generally have a viscosity of greater than about 5 to 10 centistokes at 25° C., and may range in viscosity up to about 1,000,000 centipoise at 25° C. Examples of nonvolatile oils include, but are not limited to:


(a). Esters


Suitable esters are mono-, di-, and triesters. The composition may comprise one or more esters selected from the group, or mixtures thereof.


(i) Monoesters


Monoesters are defined as esters formed by the reaction of a monocarboxylic acid having the formula R—COOH, wherein R is a straight or branched chain saturated or unsaturated alkyl having 2 to 45 carbon atoms, or phenyl; and an alcohol having the formula R—OH wherein R is a straight or branched chain saturated or unsaturated alkyl having 2-30 carbon atoms, or phenyl. Both the alcohol and the acid may be substituted with one or more hydroxyl groups. Either one or both of the acid or alcohol may be a “fatty” acid or alcohol, and may have from about 6 to 30 carbon atoms, more preferably 12, 14, 16, 18, or 22 carbon atoms in straight or branched chain, saturated or unsaturated form. Examples of monoester oils that may be used in the compositions of the invention include hexyl laurate, butyl isostearate, hexadecyl isostearate, cetyl palmitate, isostearyl neopentanoate, stearyl heptanoate, isostearyl isononanoate, steary lactate, stearyl octanoate, stearyl stearate, isononyl isononanoate, and so on.


(ii). Diesters


Suitable diesters are the reaction product of a dicarboxylic acid and an aliphatic or aromatic alcohol or an aliphatic or aromatic alcohol having at least two substituted hydroxyl groups and a monocarboxylic acid. The dicarboxylic acid may contain from 2 to 30 carbon atoms, and may be in the straight or branched chain, saturated or unsaturated form. The dicarboxylic acid may be substituted with one or more hydroxyl groups. The aliphatic or aromatic alcohol may also contain 2 to 30 carbon atoms, and may be in the straight or branched chain, saturated, or unsaturated form. Preferably, one or more of the acid or alcohol is a fatty acid or alcohol, i.e. contains 12-22 carbon atoms. The dicarboxylic acid may also be an alpha hydroxy acid. The ester may be in the dimer or trimer form. Examples of diester oils that may be used in the compositions of the invention include diisotearyl malate, neopentyl glycol dioctanoate, dibutyl sebacate, dicetearyl dimer dilinoleate, dicetyl adipate, diisocetyl adipate, diisononyl adipate, diisostearyl dimer dilinoleate, diisostearyl fumarate, diisostearyl malate, dioctyl malate, and so on.


(iii). Triesters


Suitable triesters comprise the reaction product of a tricarboxylic acid and an aliphatic or aromatic alcohol or alternatively the reaction product of an aliphatic or aromatic alcohol having three or more substituted hydroxyl groups with a monocarboxylic acid. As with the mono- and diesters mentioned above, the acid and alcohol contain 2 to 30 carbon atoms, and may be saturated or unsaturated, straight or branched chain, and may be substituted with one or more hydroxyl groups. Preferably, one or more of the acid or alcohol is a fatty acid or alcohol containing 12 to 22 carbon atoms. Examples of triesters include esters of arachidonic, citric, or behenic acids, such as triarachidin, tributyl citrate, triisostearyl citrate, tri C12-13 alkyl citrate, tricaprylin, tricaprylyl citrate, tridecyl behenate, trioctyldodecyl citrate, tridecyl behenate; or tridecyl cocoate, tridecyl isononanoate, and so on.


Esters suitable for use in the composition are further described on pages 1670-1676 of the C.T.F.A. Cosmetic Ingredient Dictionary and Handbook, Eighth Edition, 2000, which is hereby incorporated by reference in its entirety.


(b). Hydrocarbon Oils


It may be desirable to incorporate one or more nonvolatile hydrocarbon oils into the composition. Suitable nonvolatile hydrocarbon oils include paraffinic hydrocarbons and olefins, preferably those having greater than about 20 carbon atoms. Examples of such hydrocarbon oils include C24-28 olefins, C30-45 olefins, C20-40 isoparaffins, hydrogenated polyisobutene, polyisobutene, polydecene, hydrogenated polydecene, mineral oil, pentahydrosqualene, squalene, squalane, and mixtures thereof. In one preferred embodiment such hydrocarbons have a molecular weight ranging from about 300 to 1000 Daltons.


(c). Glyceryl Esters of Fatty Acids


Synthetic or naturally occurring glyceryl esters of fatty acids, or triglycerides, are also suitable for use in the compositions. Both vegetable and animal sources may be used. Examples of such oils include castor oil, lanolin oil, C10-18 triglycerides, caprylic/capric/triglycerides, sweet almond oil, apricot kernel oil, sesame oil, camelina sativa oil, tamanu seed oil, coconut oil, corn oil, cottonseed oil, linseed oil, ink oil, olive oil, palm oil, illipe butter, rapeseed oil, soybean oil, grapeseed oil, sunflower seed oil, walnut oil, and the like.


Also suitable are synthetic or semi-synthetic glyceryl esters, such as fatty acid mono-, di-, and triglycerides which are natural fats or oils that have been modified, for example, mono-, di- or triesters of polyols such as glycerin. In an example, a fatty (C12-22) carboxylic acid is reacted with one or more repeating glyceryl groups. glyceryl stearate, diglyceryl diiosostearate, polyglyceryl-3 isostearate, polyglyceryl-4 isostearate, polyglyceryl-6 ricinoleate, glyceryl dioleate, glyceryl diisotearate, glyceryl tetraisostearate, glyceryl trioctanoate, diglyceryl distearate, glyceryl linoleate, glyceryl myristate, glyceryl isostearate, PEG castor oils, PEG glyceryl oleates, PEG glyceryl stearates, PEG glyceryl tallowates, and so on.


(d). Nonvolatile Silicones


Nonvolatile silicone oils, both water soluble and water insoluble, are also suitable for use in the composition. Such silicones preferably have a viscosity ranging from about 10 to 800,000 cst, preferably 20 to 200,000 cst at 25° C. Suitable water insoluble silicones include amine functional silicones such as amodimethicone; phenyl substituted silicones such as bisphenylhexamethicone, trimethylsiloxyphenyl dimethicone, phenyl trimethicone, or polyphenylmethylsiloxane; dimethicone, dimethicone substituted with C2-30 alkyl groups such cetyl dimethicone.


Nonvolatile silicones may have the following general formula:




embedded image



wherein R and R′ are each independently C1-30 straight or branched chain, saturated or unsaturated alkyl, phenyl or aryl, trialkylsiloxy, and x and y are each independently 0-1,000,000; with the proviso that there is at least one of either x or y, and A is alkyl siloxy endcap unit. Preferred is where A is a methyl siloxy endcap unit; in particular trimethylsiloxy, and R and R′ are each independently a C1-30 straight or branched chain alkyl, phenyl, or trimethylsiloxy, more preferably a C1-22 alkyl, phenyl, or trimethylsiloxy, most preferably methyl, phenyl, or trimethylsiloxy, and resulting silicone is dimethicone, phenyl dimethicone, diphenyl dimethicone, phenyl trimethicone, or trimethylsiloxyphenyl dimethicone. Other examples include alkyl dimethicones such as cetyl dimethicone, and the like wherein at least one R is a fatty alkyl (C12, C14, C16, C18, C20, or C22), and the other R is methyl, and A is a trimethylsiloxy endcap unit, provided such alkyl dimethicone is a pourable liquid at room temperature. Phenyl trimethicone can be purchased from Dow Corning Corporation under the tradename 556 Fluid. Trimethylsiloxyphenyl dimethicone can be purchased from Wacker-Chemie under the tradename PDM-1000. Cetyl dimethicone, also referred to as a liquid silicone wax, may be purchased from Dow Corning as Fluid 2502, or from DeGussa Care & Surface Specialties under the tradenames Abil Wax 9801, or 9814.


(e). Fluorinated Oils


Various types of fluorinated oils may also be suitable for use in the compositions including but not limited to fluorinated silicones, fluorinated esters, or perfluropolyethers. Particularly suitable are fluorosilicones such as trimethylsilyl endcapped fluorosilicone oil, polytrifluoropropylmethylsiloxanes, and similar silicones such as those disclosed in U.S. Pat. No. 5,118,496 which is hereby incorporated by reference. Perfluoropolyethers include those disclosed in U.S. Pat. Nos. 5,183,589, 4,803,067, 5,183,588 all of which are hereby incorporated by reference, which are commercially available from Montefluos under the trademark Fomblin.


III. Structuring Agents


It is often desirable to structure, or increase the viscosity of anhydrous compositions, particular those found in the semi-solid or solid form. In the case where the composition is in the anhydrous emulsion form the structuring agent may be found in the nonaqueous polar solvent phase. Alternatively where the composition comprises a lipophilic oil phase, the structuring agent may be found in the oil phase. The term “oil phase structuring agent” means an ingredient or combination of ingredients, soluble or dispersible in the oil phase, which will increase the viscosity, or structure, the oil phase. The term “nonaqueous phase structuring agent” means an ingredient or combination of ingredients, soluble or dispersible in the nonaqueous polar solvent phase, if present, that will increase the viscosity or structure the nonaqueous polar solvent phase of the composition. The structuring agent used should be compatible with the resveratrol derivative and the rest of the formulation ingredients. The term “compatible” means that the structuring agent and resveratrol derivative are capable of being formulated into a cosmetic product that is generally stable. The structuring agent may be present in an amount sufficient to provide a liquid composition with increased viscosity, a semi-solid, or in some cases a solid composition that may be self-supporting. The structuring agent itself may be present in the liquid, semi-solid, or solid form. Suggested ranges of structuring agent are from about 0.01 to 70%, preferably from about 0.05 to 50%, more preferably from about 0.1-35% by weight of the total composition. Suitable oil phase structuring agents include those that are silicone based or organic based. They may be polymers or non-polymers, synthetic, natural, or a combination of both. Suitable aqueous phase structuring agents generally include those that are more hydrophilic in character.


A. Oil Phase Structuring Agents


1. Silicone Structuring Agents


A variety of oil phase structuring agents may be silicone based, such as silicone elastomers, silicone gums, silicone waxes, linear silicones having a degree of polymerization that provides the silicone with a degree of viscosity such that when incorporated into the cosmetic composition it is capable of increasing the viscosity of the oil phase. Examples of silicone structuring agents include, but are not limited to:


(a). Silicone Elastomers


Silicone elastomers suitable for use in the compositions of the invention include those that are formed by addition reaction-curing, by reacting an SiH-containing diorganosiloxane and an organopolysiloxane having terminal olefinic unsaturation, or an alpha-omega diene hydrocarbon, in the presence of a platinum metal catalyst. Such elastomers may also be formed by other reaction methods such as condensation-curing organopolysiloxane compositions in the presence of an organotin compound via a dehydrogenation reaction between hydroxyl-terminated diorganopolysiloxane and SiH-containing diorganopolysiloxane or alpha omega diene; or by condensation-curing organopolysiloxane compositions in the presence of an organotin compound or a titanate ester using a condensation reaction between an hydroxyl-terminated diorganopolysiloxane and a hydrolysable organosiloxane; peroxide-curing organopolysiloxane compositions which thermally cure in the presence of an organoperoxide catalyst.


One type of elastomer that may be suitable is prepared by addition reaction-curing an organopolysiloxane having at least 2 lower alkenyl groups in each molecule or an alpha-omega diene; and an organopolysiloxane having at least 2 silicon-bonded hydrogen atoms in each molecule; and a platinum-type catalyst. While the lower alkenyl groups such as vinyl, can be present at any position in the molecule, terminal olefinic unsaturation on one or both molecular terminals is preferred. The molecular structure of this component may be straight chain, branched straight chain, cyclic, or network. These organopolysiloxanes are exemplified by methylvinylsiloxanes, methylvinylsiloxane-dimethylsiloxane copolymers, dimethylvinylsiloxy-terminated dimethylpolysiloxanes, dimethylvinylsiloxy-terminated dimethylsiloxane-methylphenylsiloxane copolymers, dimethylvinylsiloxy-terminated dimethylsiloxane-diphenylsiloxane-methylvinylsiloxane copolymers, trimethylsiloxy-terminated dimethylsiloxane-methylvinylsiloxane copolymers, trimethylsiloxy-terminated dimethylsiloxane-methylphenylsiloxane-methylvinylsiloxane copolymers, dimethylvinylsiloxy-terminated methyl(3,3,3-trifluoropropyl)polysiloxanes, and dimethylvinylsiloxy-terminated dimethylsiloxane-methyl(3,3,-trifluoropropyl)siloxane copolymers, decadiene, octadiene, heptadiene, hexadiene, pentadiene, or tetradiene, or tridiene.


Curing proceeds by the addition reaction of the silicon-bonded hydrogen atoms in the dimethyl methylhydrogen siloxane, with the siloxane or alpha-omega diene under catalysis using the catalyst mentioned herein. To form a highly crosslinked structure, the methyl hydrogen siloxane must contain at least 2 silicon-bonded hydrogen atoms in each molecule in order to optimize function as a crosslinker.


The catalyst used in the addition reaction of silicon-bonded hydrogen atoms and alkenyl groups, and is concretely exemplified by chloroplatinic acid, possibly dissolved in an alcohol or ketone and this solution optionally aged, chloroplatinic acid-olefin complexes, chloroplatinic acid-alkenylsiloxane complexes, chloroplatinic acid-diketone complexes, platinum black, and carrier-supported platinum.


Examples of suitable silicone elastomers for use in the compositions of the invention may be in the powder form, or dispersed or solubilized in solvents such as volatile or non-volatile silicones, or silicone compatible vehicles such as paraffinic hydrocarbons or esters. Examples of silicone elastomer powders include vinyl dimethicone/methicone silesquioxane crosspolymers like Shin-Etsu's KSP-100, KSP-101, KSP-102, KSP-103, KSP-104, KSP-105, hybrid silicone powders that contain a fluoroalkyl group like Shin-Etsu's KSP-200 which is a fluoro-silicone elastomer, and hybrid silicone powders that contain a phenyl group such as Shin-Etsu's KSP-300, which is a phenyl substituted silicone elastomer; and Dow Corning's DC 9506. Examples of silicone elastomer powders dispersed in a silicone compatible vehicle include dimethicone/vinyl dimethicone crosspolymers supplied by a variety of suppliers including Dow Corning Corporation under the tradenames 9040 or 9041, GE Silicones under the tradename SFE 839, or Shin-Etsu Silicones under the tradenames KSG-15, 16, 18. KSG-15 has the CTFA name cyclopentasiloxane/dimethicone/vinyl dimethicone crosspolymer. KSG-18 has the INCI name phenyl trimethicone/dimethicone/phenyl vinyl dimethicone crossoplymer. Silicone elastomers may also be purchased from Grant Industries under the Gransil trademark. Also suitable are silicone elastomers having long chain alkyl substitutions such as lauryl dimethicone/vinyl dimethicone crosspolymers supplied by Shin Etsu under the tradenames KSG-31, KSG-32, KSG-41, KSG-42, KSG-43, and KSG-44. Cross-linked organopolysiloxane elastomers useful in the present invention and processes for making them are further described in U.S. Pat. No. 4,970,252 to Sakuta et al., issued Nov. 13, 1990; U.S. Pat. No. 5,760,116 to Kilgour et al., issued Jun. 2, 1998; U.S. Pat. No. 5,654,362 to Schulz, Jr. et al. issued Aug. 5, 1997; and Japanese Patent Application JP 61-18708, assigned to Pola Kasei Kogyo K K, each of which are herein incorporated by reference in its entirety.


(b). Silicone Gums


Also suitable for use as an oil phase structuring agent are one or more silicone gums. The term “gum” means a silicone polymer having a degree of polymerization sufficient to provide a silicone having a gum-like texture. In certain cases the silicone polymer forming the gum may be crosslinked. The silicone gum typically has a viscosity ranging from about 500,000 to 100 million cst at 25° C., preferably from about 600,000 to 20 million, more preferably from about 600,000 to 12 million cst. All ranges mentioned herein include all subranges, e.g. 550,000; 925,000; 3.5 million.


The silicone gums that are used in the compositions include, but are not limited to, those of the general formula wherein:




embedded image



R1 to R9 are each independently an alkyl having 1 to 30 carbon atoms, aryl, or aralkyl; and X is OH or a C1-30 alkyl, or vinyl; and wherein x, y, or z may be zero with the proviso that no more than two of x, y, or z are zero at any one time, and further that x, y, and z are such that the silicone gum has a viscosity of at least about 500,000 cst, ranging up to about 100 million centistokes at 25° C. Preferred is where R is methyl or OH.


Such silicone gums may be purchased in pure form from a variety of silicone manufacturers including Wacker-Chemie or Dow Corning, and the like. Such silicone gums include those sold by Wacker-Belsil under the trade names CM3092, Wacker-Belsil 1000, or Wacker-Belsil DM 3096. A silicone gum where X is OH, also referred to as dimethiconol, is available from Dow Corning Corporation under the trade name 1401. The silicone gum may also be purchased in the form of a solution or dispersion in a silicone compatible vehicle such as volatile or nonvolatile silicone. An example of such a mixture may be purchased from Bamet Silicones under the HL-88 tradename, having the INCI name dimethicone.


(c). Silicone Waxes


Another type of oily phase structuring agent includes silicone waxes that are typically referred to as alkyl silicone waxes which are semi-solids or solids at room temperature. The term “alkyl silicone wax” means a polydimethylsiloxane having a substituted long chain alkyl (such as C16 to 30) that confers a semi-solid or solid property to the siloxane. Examples of such silicone waxes include stearyl dimethicone, which may be purchased from DeGussa Care & Surface Specialties under the tradename Abil Wax 9800 or from Dow Corning under the tradename 2503. Another example is bis-stearyl dimethicone, which may be purchased from Gransil Industries under the tradename Gransil A-18, or behenyl dimethicone, behenoxy dimethicone.


(d). Polyamides or Silicone Polyamides


Also suitable as oil phase structuring agents are various types of polymeric compounds such as polyamides or silicone polyamides.


The term silicone polyamide means a polymer comprised of silicone monomers and monomers containing amide groups as further described herein. The silicone polyamide preferably comprises moieties of the general formula:




embedded image


  • X is a linear or branched alkylene having from about 1-30 carbon atoms;

  • R1, R2, R3, and R4 are each independently C1-30 straight or branched chain alkyl which may be substituted with one or more hydroxyl or halogen groups; phenyl which may be substituted with one or more C1-30 alkyl groups, halogen, hydroxyl, or alkoxy groups; or a siloxane chain having the general formula:





embedded image



and Y is:


(a) a linear or branched alkylene having from about 1-40 carbon atoms which may be substituted with (i) one or more amide groups having the general formula R1CONR1, or (ii) C5-6 cyclic ring, or (iii) phenylene which may be substituted with one or more C1-10 alkyl groups, or (iv) hydroxy, or (v) C3-8 cycloalkane, or (vi) C1-20 alkyl which may be substituted with one or more hydroxy groups, or (vii) C1-10 alkyl amines; or


(b) TR5R6R7


wherein R5, R6, and R7, are each independently a C1-10 linear or branched alkylenes, and T is CR8 wherein R8 is hydrogen, a trivalent atom N, P, or Al, or a C1-30 straight or branched chain alkyl which may be substituted with one or more hydroxyl or halogen groups; phenyl which may be substituted with one or more C1-30 alkyl groups, halogen, hydroxyl, or alkoxy groups; or a siloxane chain having the general formula:




embedded image


Preferred is where R1, R2, R3, and R4 are C1-10, preferably methyl; and X and Y is a linear or branched alkylene. Preferred are silicone polyamides having the general formula




embedded image



wherein a and b are each independently sufficient to provide a silicone polyamide polymer having a melting point ranging from about 60 to 120° C., and a molecular weight ranging from about 40,000 to 500,000 Daltons. One type of silicone polyamide that may be used in the compositions of the invention may be purchased from Dow Corning Corporation under the tradename Dow Corning 2-8178 gellant which has the CTFA name nylon-611/dimethicone copolymer which is sold in a composition containing PPG-3 myristyl ether.


Also suitable are polyamides such as those purchased from Arizona Chemical under the tradenames Uniclear and Sylvaclear. Such polyamides may be ester terminated or amide terminated. Examples of ester terminated polyamides include, but are not limited to those having the general formula:




embedded image



wherein n denotes a number of amide units such that the number of ester groups ranges from about 10% to 50% of the total number of ester and amide groups; each R1 is independently an alkyl or alkenyl group containing at least 4 carbon atoms; each R2 is independently a C4-42 hydrocarbon group, with the proviso that at least 50% of the R2 groups are a C30-42 hydrocarbon; each R3 is independently an organic group containing at least 2 carbon atoms, hydrogen atoms and optionally one or more oxygen or nitrogen atoms; and each R4 is independently a hydrogen atom, a C1-10 alkyl group or a direct bond to R3 or to another R4, such that the nitrogen atom to which R3 and R4 are both attached forms part of a heterocyclic structure defined by R4—N—R3, with at least 50% of the groups R4 representing a hydrogen atom.


General examples of ester and amide terminated polyamides that may be used as oil phase gelling agents include those sold by Arizona Chemical under the tradenames Sylvaclear A200V or A2614V, both having the CTFA name ethylenediamine/hydrogenated dimer dilinoleate copolymer/bis-di-C14-18 alkyl amide; Sylvaclear AF1900V; Sylvaclear C75V having the CTFA name bis-stearyl ethylenediamine/neopentyl glycol/stearyl hydrogenated dimer dilinoleate copolymer; Sylvaclear PA1200V having the CTFA name Polyamide-3; Sylvaclear PE400V; Sylvaclear WF1500V; or Uniclear, such as Uniclear 100VG having the INCI name ethylenediamine/stearyl dimer dilinoleate copolymer; or ethylenediamine/stearyl dimer ditallate copolymer. Other examples of suitable polyamides include those sold by Henkel under the Versamid trademark (such as Versamid 930, 744, 1655), or by Olin Mathieson Chemical Corp. under the brand name Onamid S or Onamid C.


(e). Natural or Synthetic Organic Waxes


Also suitable as the oil phase structuring agent may be one or more natural or synthetic waxes such as animal, vegetable, or mineral waxes. Preferably such waxes will have a higher melting point such as from about 60 to 150° C., more preferably from about 65 to 100° C. Examples of such waxes include waxes made by Fischer-Tropsch synthesis, such as polyethylene or synthetic wax; or various vegetable waxes such as bayberry, candelilla, ozokerite, acacia, beeswax, ceresin, cetyl esters, flower wax, citrus wax, carnauba wax, jojoba wax, japan wax, polyethylene, microcrystalline, rice bran, lanolin wax, mink, montan, bayberry, ouricury, ozokerite, palm kernel wax, paraffin, avocado wax, apple wax, shellac wax, clary wax, spent grain wax, grape wax, and polyalkylene glycol derivatives thereof such as PEG6-20 beeswax, or PEG-12 carnauba wax; or fatty acids or fatty alcohols, including esters thereof, such as hydroxystearic acids (for example 12-hydroxy stearic acid), tristearin, tribehenin, and so on.


(f). Montmorillonite Minerals


One type of structuring agent that may be used in the composition comprises natural or synthetic montmorillonite minerals such as hectorite, bentonite, and quaternized derivatives thereof, which are obtained by reacting the minerals with a quaternary ammonium compound, such as stearalkonium bentonite, hectorites, quaternized hectorites such as Quaternium-18 hectorite, attapulgite, carbonates such as propylene carbonate, bentones, and the like.


(g). Silicas and Silicates


Another type of structuring agent that may be used in the compositions are silicas, silicates, silica silylate, and alkali metal or alkaline earth metal derivatives thereof. These silicas and silicates are generally found in the particulate form and include silica, silica silylate, magnesium aluminum silicate, and the like.


B. Non-Aqueous Polar Solvent Structuring Agents


If desired, a variety of structuring agents that are soluble or dispersible in the nonaqueous polar solvent phase, if present, may be used. Such agents will typically thicken or increase the viscosity of the nonaqueous polar solvent phase of the anhydrous emulsion. If present, suggested ranges are from about 0.01 to 30%, preferably from about 0.1 to 20%, more preferably from about 0.5 to 15% by weight of the total composition. Examples of such agents include various acrylate based thickening agents, natural or synthetic gums, polysaccharides, and the like.


1. Polysaccharides


A variety of polysaccharides in various forms may be suitable thickening agents for the nonaqueous polar solvent, if present. Examples of such polysaccharides include naturally derived materials such as agar, agarose, alicaligenes polysaccharides, algin, alginic acid, amylopectin, chitin, dextran, cassia gum, cellulose gum, gelatin, gellan gum, hyaluronic acid, hydroxyethyl cellulose, methyl cellulose, ethyl cellulose, pectin, sclerotium gum, xanthan gum, pectin, trehelose, gelatin, and so on.


2. Acrylate Polymers


Also suitable as thickeners for the nonaqueous polar solvent phase, if present, may be various types of acrylic polymeric thickeners comprised of monomers A and B wherein A is selected from the group consisting of acrylic acid, methacrylic acid, and mixtures thereof, and B is selected from the group consisting of a C1-22 alkyl acrylate, a C1-22 alky methacrylate, and mixtures thereof are suitable. In one embodiment the A monomer comprises one or more of acrylic acid or methacrylic acid, and the B monomer is selected from the group consisting of a C1-10, most preferably C1-4 alkyl acrylate, a C1-10, most preferably C1-4 alkyl methacrylate, and mixtures thereof. Most preferably the B monomer is one or more of methyl or ethyl acrylate or methacrylate.


Also suitable are acrylic polymeric thickeners that are copolymer of A, B, and C monomers wherein A and B are as defined above, and C has the general formula:




embedded image



wherein Z is —(CH2)m; wherein m is 1-10, n is 2-3, o is 2-200, and R is a C10-30 straight or branched chain alkyl. Examples of the secondary thickening agent above, are copolymers where A and B are defined as above, and C is CO, and wherein n, o, and R are as above defined. Examples of such secondary thickening agents include acrylates/steareth-20 methacrylate copolymer, which is sold by Rohm & Haas under the tradename Acrysol ICS-1.


Also suitable are acrylate based anionic amphiphilic polymers containing at least one hydrophilic unit and at least one allyl ether unit containing a fatty chain. Preferred are those where the hydrophilic unit contains an ethylenically unsaturated anionic monomer, more specifically a vinyl carboxylic acid such as acrylic acid, methacrylic acid or mixtures thereof, and where the allyl ether unit containing a fatty chain corresponds to the monomer of formula

CH2═CR′CH2OBnR

in which R′ denotes H or CH3, B denotes the ethylenoxy radical, n is zero or an integer ranging from 1 to 100, R denotes a hydrocarbon radical selected from alkyl, arylalkyl, aryl, alkylaryl and cycloalkyl radicals which contain from 8 to 30 carbon atoms, preferably from 10 to 24, and even more particularly from 12 to 18 carbon atoms. More preferred in this case is where R′ denotes H, n is equal to 10 and R denotes a stearyl (C18) radical. Anionic amphiphilic polymers of this type are described and prepared in U.S. Pat. Nos. 4,677,152 and 4,702,844, both of which are hereby incorporated by reference in their entirety. Among these anionic amphiphilic polymers, polymers formed of 20 to 60% by weight acrylic acid and/or methacrylic acid, of 5 to 60% by weight lower alkyl methacrylates, of 2 to 50% by weight allyl ether containing a fatty chain as mentioned above, and of 0 to 1% by weight of a crosslinking agent which is a well-known copolymerizable polyethylenic unsaturated monomer, for instance diallyl phthalate, allyl(meth)acrylate, divinylbenzene, (poly)ethylene glycol dimethacrylate and methylenebisacrylamide.


Also suitable are acrylate copolymers such as Polyacrylate-3 which is a copolymer of methacrylic acid, methylmethacrylate, methylstyrene isopropylisocyanate, and PEG-40 behenate monomers; Polyacrylate-10 which is a copolymer of sodium acryloyldimethyltaurate, sodium acrylate, acrylamide and vinyl pyrrolidone monomers; or Polyacrylate-11, which is a copolymer of sodium acryloyldimethylacryloyldimethyl taurate, sodium acrylate, hydroxyethyl acrylate, lauryl acrylate, butyl acrylate, and acrylamide monomers.


Also suitable are crosslinked acrylate based polymers where one or more of the acrylic groups may have substituted long chain alkyl (such as 6-40, 10-30, and the like) groups, for example acrylates/C10-30 alkyl acrylate crosspolymer which is a copolymer of C10-30 alkyl acrylate and one or more monomers of acrylic acid, methacrylic acid, or one of their simple esters crosslinked with the allyl ether of sucrose or the allyl ether of pentaerythritol. Such polymers are commonly sold under the Carbopol or Pemulen tradenames.


Also suitable for use in thickening the nonaqueous polar solvent phase, if present, are acrylate based polymeric thickeners sold by Clariant under the Aristoflex trademark such as Aristoflex AVC, which is ammonium acryloyldimethyltaurate/VP copolymer; Aristoflex AVL which is the same polymer has found in AVC dispersed in mixture containing caprylic/capric triglyceride, trilaureth-4, and polyglyceryl-2 sesquiisostearate; or Aristoflex HMB which is ammonium acryloyldimethyltaurate/beheneth-25 methacrylate crosspolymer, and the like.


3. High Molecular Weight PEG or Polyglycerins


Also suitable as thickeners for the nonaqueous polar phase, if present, are various polyethylene glycols (PEG) derivatives where the degree of polymerization ranges from 1,000 to 200,000. Such ingredients are indicated by the designation “PEG” followed by the degree of polymerization in thousands, such as PEG-45M, which means PEG having 45,000 repeating ethylene oxide units. Examples of suitable PEG derivatives include PEG 2M, 5M, 7M, 9M, 14M, 20M, 23M, 25M, 45M, 65M, 90M, 115M, 160M, 180M, and the like.


Also suitable are polyglycerins which are repeating glycerin moieties where the number of repeating moieties ranges from 15 to 200, preferably from about 20-100. Examples of suitable polyglycerins include those having the CFTA names polyglycerin-20, polyglycerin-40, and the like.


IV. Other Ingredients


The anhydrous compositions of the invention may contain a variety of other ingredients including, but not limited to, surfactants, botanicals, sugars, humectants, preservatives, peptides, and the like, including but not limited to those mentioned herein.


A. Surfactants


It may be desirable to include one or more surfactants in the composition in order to aid in dispersing particulates or other ingredients that may be present. The surfactants may be silicone or organic. The surfactants will aid in the formation of stable anhydrous emulsions, or anhydrous dispersions. If present, the surfactant may range from about 0.001 to 30%, preferably from about 0.005 to 25%, more preferably from about 0.1 to 20% by weight of the total composition.


1. Silicone Surfactants


Suitable silicone surfactants include polyorganosiloxane polymers that have amphiphilic properties, for example contain hydrophilic radicals and lipophilic radicals. These silicone surfactants may be liquids or solids at room temperature.


(a). Dimethicone Copolyols or Alkyl Dimethicone Copolyols


One type of silicone surfactant that may be used is generally referred to as dimethicone copolyol or alkyl dimethicone copolyol. This surfactant is either a water-in-oil or oil-in-water surfactant having an Hydrophile/Lipophile Balance (HLB) ranging from about 2 to 18. Preferably the silicone surfactant is a nonionic surfactant having an HLB ranging from about 2 to 12, preferably about 2 to 10, most preferably about 4 to 6. The term “hydrophilic radical” means a radical that, when substituted onto the organosiloxane polymer backbone, confers hydrophilic properties to the substituted portion of the polymer. Examples of radicals that will confer hydrophilicity are hydroxy-polyethyleneoxy, hydroxyl, carboxylates, and mixtures thereof. The term “lipophilic radical” means an organic radical that, when substituted onto the organosiloxane polymer backbone, confers lipophilic properties to the substituted portion of the polymer. Examples of organic radicals that will confer lipophilicity are C1-40 straight or branched chain alkyl, fluoro, aryl, aryloxy, C1-40 hydrocarbyl acyl, hydroxy-polypropyleneoxy, or mixtures thereof.


One type of suitable silicone surfactant has the general formula:




embedded image



wherein p is 0-40 (the range including all numbers between and subranges such as 2, 3, 4, 13, 14, 15, 16, 17, 18, etc.), and PE is (—C2H4O)a—(—C3H6O)b—H wherein a is 0 to 25, b is 0-25 with the proviso that both a and b cannot be 0 simultaneously, x and y are each independently ranging from 0 to 1 million with the proviso that they both cannot be 0 simultaneously. In one preferred embodiment, x, y, z, a, and b are such that the molecular weight of the polymer ranges from about 5,000 to about 500,000, more preferably from about 10,000 to 100,000, and is most preferably approximately about 50,000 and the polymer is generically referred to as dimethicone copolyol.


One type of silicone surfactant is wherein p is such that the long chain alkyl is cetyl or lauryl, and the surfactant is called, generically, cetyl dimethicone copolyol or lauryl dimethicone copolyol respectively.


In some cases the number of repeating ethylene oxide or propylene oxide units in the polymer are also specified, such as a dimethicone copolyol that is also referred to as PEG-15/PPG-10 dimethicone, which refers to a dimethicone having substituents containing 15 ethylene glycol units and 10 propylene glycol units on the siloxane backbone. It is also possible for one or more of the methyl groups in the above general structure to be substituted with a longer chain alkyl (e.g. ethyl, propyl, butyl, etc.) or an ether such as methyl ether, ethyl ether, propyl ether, butyl ether, and the like.


Examples of silicone surfactants are those sold by Dow Corning under the tradename Dow Corning 3225C Formulation Aid having the CTFA name cyclotetrasiloxane (and) cyclopentasiloxane (and) PEG/PPG-18 dimethicone; or 5225C Formulation Aid, having the CTFA name cyclopentasiloxane (and) PEG/PPG-18/18 dimethicone; or Dow Corning 190 Surfactant having the CTFA name PEG/PPG-18/18 dimethicone; or Dow Corning 193 Fluid, Dow Corning 5200 having the CTFA name lauryl PEG/PPG-18/18 methicone; or Abil EM 90 having the CTFA name cetyl PEG/PPG-14/14 dimethicone sold by Goldschmidt; or Abil EM 97 having the CTFA name bis-cetyl PEG/PPG-14/14 dimethicone sold by Goldschmidt; or Abil WE 09 having the CTFA name cetyl PEG/PPG-10/1 dimethicone in a mixture also containing polyglyceryl-4 isostearate and hexyl laurate; or KF-6011 sold by Shin-Etsu Silicones having the CTFA name PEG-11 methyl ether dimethicone; KF-6012 sold by Shin-Etsu Silicones having the CTFA name PEG/PPG-20/22 butyl ether dimethicone; or KF-6013 sold by Shin-Etsu Silicones having the CTFA name PEG-9 dimethicone; or KF-6015 sold by Shin-Etsu Silicones having the CTFA name PEG-3 dimethicone; or KF-6016 sold by Shin-Etsu Silicones having the CTFA name PEG-9 methyl ether dimethicone; or KF-6017 sold by Shin-Etsu Silicones having the CTFA name PEG-10 dimethicone; or KF-6038 sold by Shin-Etsu Silicones having the CTFA name lauryl PEG-9 polydimethylsiloxyethyl dimethicone.


(b). Crosslinked Silicone Surfactants


Also suitable are various types of crosslinked silicone surfactants are referred to as emulsifying elastomers. They are typically prepared as set forth above with respect to the section “silicone elastomers” except that the silicone elastomers will contain at least one hydrophilic moiety such as polyoxyalkylenated groups. Typically these polyoxyalkylenated silicone elastomers are crosslinked organopolysiloxanes that may be obtained by a crosslinking addition reaction of diorganopolysiloxane comprising at least one hydrogen bonded to silicon and of a polyoxyalkylene comprising at least two ethylenically unsaturated groups. In at least one embodiment, the polyoxyalkylenated crosslinked organo-polysiloxanes are obtained by a crosslinking addition reaction of a diorganopolysiloxane comprising at least two hydrogens each bonded to a silicon, and a polyoxyalkylene comprising at least two ethylenically unsaturated groups, optionally in the presence of a platinum catalyst, as described, for example, in U.S. Pat. Nos. 5,236,986 and 5,412,004, 5,837,793 and 5,811,487, the contents of which are incorporated by reference.


Polyoxyalkylenated silicone elastomers that may be used in at least one embodiment of the invention include those sold by Shin-Etsu Silicones under the names KSG-21 , KSG-20, KSG-30, KSG-31, KSG-32, KSG-33; KSG-210 which is dimethicone/PEG-10/15 crosspolymer dispersed in dimethicone; KSG-310 which is PEG-15 lauryl dimethicone crosspolymer; KSG-320 which is PEG-15 lauryl dimethicone crosspolymer dispersed in isododecane; KSG-330 (the former dispersed in triethylhexanoin), KSG-340 which is a mixture of PEG-10 lauryl dimethicone crosspolymer and PEG-15 lauryl dimethicone crosspolymer.


Also suitable are polyglycerolated silicone elastomers like those disclosed in PCT/WO 2004/024798, which is hereby incorporated by reference in its entirety. Such elastomers include Shin-Etsu's KSG series, such as KSG-710 which is dimethicone/polyglycerin-3 crosspolymer dispersed in dimethicone; or lauryl dimethicone/polyglycerin-3 crosspolymer dispersed in a variety of solvent such as isododecane, dimethicone, triethylhexanoin, sold under the Shin-Etsu tradenames KSG-810, KSG-820, KSG-830, or KSG-840. Also suitable are silicones sold by Dow Corning under the tradenames 9010 and DC9011.


One preferred crosslinked silicone elastomer emulsifier is dimethicone/PEG-10/15 crosspolymer.


(c). Organic Nonionic Surfactants


The composition may comprise one or more nonionic organic surfactants. Suitable nonionic surfactants include alkoxylated alcohols, or ethers, formed by the reaction of an alcohol with an alkylene oxide, usually ethylene or propylene oxide. Preferably the alcohol is either a fatty alcohol having 6 to 30 carbon atoms Examples of such ingredients include Steareth 2-100, which is formed by the reaction of stearyl alcohol and ethylene oxide and the number of ethylene oxide units ranges from 2 to 100; Beheneth 5-30 which is formed by the reaction of behenyl alcohol and ethylene oxide where the number of repeating ethylene oxide units is 5 to 30; Ceteareth 2-100, formed by the reaction of a mixture of cetyl and stearyl alcohol with ethylene oxide, where the number of repeating ethylene oxide units in the molecule is 2 to 100; Ceteth 1-45 which is formed by the reaction of cetyl alcohol and ethylene oxide, and the number of repeating ethylene oxide units is 1 to 45, and so on.


Other alkoxylated alcohols are formed by the reaction of fatty acids and mono-, di- or polyhydric alcohols with an alkylene oxide. For example, the reaction products of C6-30 fatty carboxylic acids and polyhydric alcohols which are monosaccharides such as glucose, galactose, methyl glucose, and the like, with an alkoxylated alcohol. Examples include polymeric alkylene glycols reacted with glyceryl fatty acid esters such as PEG glyceryl oleates, PEG glyceryl stearate; or PEG polyhydroxyalkanotes such as PEG dipolyhydroxystearate wherein the number of repeating ethylene glycol units ranges from 3 to 1000.


Also suitable as nonionic surfactants are formed by the reaction of a carboxylic acid with an alkylene oxide or with a polymeric ether. The resulting products have the general formula: where RCO is the carboxylic ester radical, X is hydrogen or lower alkyl, and n is the number of polymerized alkoxy groups. In the case of the diesters, the two RCO-groups do not need to be identical. Preferably, R is a C6-30 straight or branched chain, saturated or unsaturated alkyl, and n is from 1-100.


Monomeric, homopolymeric, or block copolymeric ethers are also suitable as nonionic surfactants. Typically, such ethers are formed by the polymerization of monomeric alkylene oxides, generally ethylene or propylene oxide. Such polymeric ethers have the following general formula: wherein R is H or lower alkyl and n is the number of repeating monomer units, and ranges from 1 to 500.


Other suitable nonionic surfactants include alkoxylated sorbitan and alkoxylated sorbitan derivatives. For example, alkoxylation, in particular ethoxylation of sorbitan provides polyalkoxylated sorbitan derivatives. Esterification of polyalkoxylated sorbitan provides sorbitan esters such as the polysorbates. For example, the polyalkyoxylated sorbitan can be esterified with C6-30, preferably C12-22 fatty acids. Examples of such ingredients include Polysorbates 20-85, sorbitan oleate, sorbitan sesquioleate, sorbitan palmitate, sorbitan sesquiisostearate, sorbitan stearate, and so on.


Certain types of amphoteric, zwitterionic, or cationic surfactants may also be used in the compositions. Descriptions of such surfactants are set forth in U.S. Pat. No. 5,843,193, which is hereby incorporated by reference in its entirety.


B. Botanical Extracts


It may be desirable to include one or more botanical extracts in the compositions. If so, suggested ranges are from about 0.0001 to 10%, preferably about 0.0005 to 8%, more preferably about 0.001 to 5% by weight of the total composition. Suitable botanical extracts include extracts from plants (herbs, roots, flowers, fruits, seeds) such as flowers, fruits, vegetables, and so on, including yeast ferment extract, padica pavonica extract, thermus thermophilis ferment extract, camelina sativa seed oil, boswellia serrata extract, olive extract, aribodopsis thaliana extract, acacia dealbata extract, acer saccharinum (sugar maple), acidopholus, acorus, aesculus, agaricus, agave, agrimonia, algae, aloe, citrus, brassica, cinnamon, orange, apple, blueberry, cranberry, peach, pear, lemon, lime, pea, seaweed, caffeine, green tea, chamomile, willowbark, mulberry, poppy, and those set forth on pages 1646 through 1660 of the CTFA Cosmetic Ingredient Handbook, Eighth Edition, Volume 2. Further specific examples include, but are not limited to, Glycyrrhiza Glabra, Salix Nigra, Macrocycstis Pyrifera, Pyrus Malus, Saxifraga Sarmentosa, Vilis Vinifera, Morus Nigra, Scutellaria Baicalensis, Anthemis Nobilis, Salvia Sclarea, Rosmarinus Officianalis, Citrus Medica Limonum, Panax Ginseng, and mixtures thereof.


C. Sunscreens


It may also be desirable to include one or more sunscreens in the compositions of the invention. Such sunscreens include chemical UVA or UVB sunscreens or physical sunscreens in the particulate form.


1. UVA Chemical Sunscreens


If desired, the composition may comprise one or more UVA sunscreens. The term “UVA sunscreen” means a chemical compound that blocks UV radiation in the wavelength range of about 320 to 400 nm. Preferred UVA sunscreens are dibenzoylmethane compounds having the general formula




embedded image



wherein R1 is H, OR and NRR wherein each R is independently H, C1-20 straight or branched chain alkyl; R2 is H or OH; and R3 is H, C1-20 straight or branched chain alkyl.


Preferred is where R1 is OR where R is a C1-20 straight or branched alkyl, preferably methyl; R2 is H; and R3 is a C1-20 straight or branched chain alkyl, more preferably, butyl.


Examples of suitable UVA sunscreen compounds of this general formula include 4-methyldibenzoylmethane, 2-methyldibenzoylmethane, 4-isopropyldibenzoylmethane, 4-tert-butyldibenzoylmethane, 2,4-dimethyldibenzoylmethane, 2,5-dimethyldibenzoylmethane, 4,4′diisopropylbenzoylmethane, 4-tert-butyl-4′-methoxydibenzoylmethane, 4,4′-diisopropylbenzoylmethane, 2-methyl-5-isopropyl-4′-methoxydibenzoymethane, 2-methyl-5-tert-butyl-4′-methoxydibenzoylmethane, and so on. Particularly preferred is 4-tert-butyl-4′-methoxydibenzoylmethane, also referred to as Avobenzone. Avobenzone is commercial available from Givaudan-Roure under the trademark Parsol 1789, and Merck & Co. under the tradename Eusolex 9020.


The composition may contain from about 0.001-20%, preferably 0.005-5%, more preferably about 0.005-3% by weight of the composition of UVA sunscreen. In the preferred embodiment of the invention the UVA sunscreen is Avobenzone, and it is present at not greater than about 3% by weight of the total composition.


2. UVB Chemical Sunscreens


The term “UVB sunscreen” means a compound that blocks UV radiation in the wavelength range of from about 290 to 320 nm. A variety of UVB chemical sunscreens exist including alpha-cyano-beta,beta-diphenyl acrylic acid esters as set forth in U.S. Pat. No. 3,215,724, which is hereby incorporated by reference in its entirety. One particular example of an alpha-cyano-beta,beta-diphenyl acrylic acid ester is Octocrylene, which is 2-ethylhexyl 2-cyano-3,3-diphenylacrylate. In certain cases the composition may contain no more than about 110% by weight of the total composition of octocrylene. Suitable amounts range from about 0.001-10% by weight. Octocrylene may be purchased from BASF under the tradename Uvinul N-539.


Other suitable sunscreens include benzylidene camphor derivatives as set forth in U.S. Pat. No. 3,781,417, which is hereby incorporated by reference in its entirety. Such benzylidene camphor derivatives have the general formula:




embedded image



wherein R is p-tolyl or styryl, preferably styryl. Particularly preferred is 4-methylbenzylidene camphor, which is a lipid soluble UVB sunscreen compound sold under the tradename Eusolex 6300 by Merck.


Also suitable are cinnamate derivatives having the general formula:




embedded image



wherein R and R1 are each independently a C1-20 straight or branched chain alkyl. Preferred is where R is methyl and R1 is a branched chain C1-10, preferably C8 alkyl. The preferred compound is ethylhexyl methoxycinnamate, also referred to as Octoxinate or octyl methoxycinnamate. The compound may be purchased from Givaudan Corporation under the tradename Parsol MCX, or BASF under the tradename Uvinul MC 80. Also suitable are mono-, di-, and triethanolamine derivatives of such methoxy cinnamates including diethanolamine methoxycinnamate. Cinoxate, the aromatic ether derivative of the above compound is also acceptable. If present, the Cinoxate should be found at no more than about 3% by weight of the total composition.


Also suitable as UVB screening agents are various benzophenone derivatives having the general formula:




embedded image



wherein R through R9 are each independently H, OH, NaO3S, SO3H, SO3Na, Cl, R″, OR″ where R″ is C1-20 straight or branched chain alkyl Examples of such compounds include Benzophenone 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12. Particularly preferred is where the benzophenone derivative is Benzophenone 3 (also referred to as Oxybenzone), Benzophenone 4 (also referred to as Sulisobenzone), Benzophenone 5 (Sulisobenzone Sodium), and the like. Most preferred is Benzophenone 3.


Also suitable are certain menthyl salicylate derivatives having the general formula:




embedded image



wherein R1, R2, R3, and R4 are each independently H, OH, NH2, or C1-20 straight or branched chain alkyl. Particularly preferred is where R1, R2, and R3 are methyl and R4 is hydroxyl or NH2, the compound having the name homomenthyl salicylate (also known as Homosalate) or menthyl anthranilate. Homosalate is available commercially from Merck under the tradename Eusolex HMS and menthyl anthranilate is commercially available from Haarmann & Reimer under the tradename Heliopan. If present, the Homosalate should be found at no more than about 15% by weight of the total composition.


Various amino benzoic acid derivatives are suitable UVB absorbers including those having the general formula:




embedded image



wherein R1, R2, and R3 are each independently H, C1-20 straight or branched chain alkyl which may be substituted with one or more hydroxy groups. Particularly preferred is wherein R1 is H or C1-8 straight or branched alkyl, and R2 and R3 are H, or C1-8 straight or branched chain alkyl. Particularly preferred are PABA, ethyl hexyl dimethyl PABA (Padimate O), ethyldihydroxypropyl PABA, and the like. If present Padimate O should be found at no more than about 8% by weight of the total composition.


Salicylate derivatives are also acceptable UVB absorbers. Such compounds have the general formula: wherein R is a straight or branched chain alkyl, including derivatives of the above compound formed from mono-, di-, or triethanolamines. Particular preferred are octyl salicylate, TEA-salicylate, DEA-salicylate, and mixtures thereof.


Generally, the amount of the UVB chemical sunscreen present may range from about 0.001-45%, preferably 0.005-40%, more preferably about 0.01-35% by weight of the total composition.


If desired, the compositions of the invention may be formulated to have a certain SPF (sun protective factor) values ranging from about 1-50, preferably about 2-45, most preferably about 5-30. Calculation of SPF values is well known in the art. Preferably, the claimed compositions have SPF values greater than 4.


D. Particulate Materials


The compositions of the invention may contain particulate materials in the form of pigments, inert particulates, or mixtures thereof. If present, suggested ranges are from about 0.1-75%, preferably about 0.5-70%, more preferably about 0.1-65% by weight of the total composition. In the case where the composition may comprise mixtures of pigments and powders, suitable ranges include about 0.01-75% pigment and 0.1-75% powder, such weights by weight of the total composition.


1. Powders


The particulate matter may be colored or non-colored (for example white) non-pigmentatious powders. Suitable non-pigmentatious powders include bismuth oxychloride, titanated mica, fumed silica, spherical silica, polymethylmethacrylate, micronized teflon, boron nitride, acrylate copolymers, aluminum silicate, aluminum starch octenylsuccinate, bentonite, calcium silicate, cellulose, chalk, corn starch, diatomaceous earth, fuller's earth, glyceryl starch, hectorite, hydrated silica, kaolin, magnesium aluminum silicate, magnesium trisilicate, maltodextrin, montmorillonite, microcrystalline cellulose, rice starch, silica, talc, mica, titanium dioxide, zinc laurate, zinc myristate, zinc rosinate, alumina, attapulgite, calcium carbonate, calcium silicate, dextran, kaolin, nylon, silica silylate, silk powder, sericite, soy flour, tin oxide, titanium hydroxide, trimagnesium phosphate, walnut shell powder, or mixtures thereof. The above mentioned powders may be surface treated with lecithin, amino acids, mineral oil, silicone, or various other agents either alone or in combination, which coat the powder surface and render the particles more lipophilic in nature.


2. Pigments


The particulate materials may comprise various organic and/or inorganic pigments. The organic pigments are generally various aromatic types including azo, indigoid, triphenylmethane, anthroquinone, and xanthine dyes which are designated as D&C and FD&C blues, browns, greens, oranges, reds, yellows, etc. Organic pigments generally consist of insoluble metallic salts of certified color additives, referred to as the Lakes. Inorganic pigments include iron oxides, ultramarines, chromium, chromium hydroxide colors, and mixtures thereof. Iron oxides of red, blue, yellow, brown, black, and mixtures thereof are suitable.


E. Preservatives


The composition may contain 0.001-8%, preferably 0.01-6%, more preferably 0.05-5% by weight of the total composition of preservatives. A variety of preservatives are suitable, including such as benzoic acid, benzyl alcohol, benzylhemiformal, benzylparaben, 5-bromo-5-nitro-1,3-dioxane, 2-bromo-2-nitropropane-1,3-diol, butyl paraben, phenoxyethanol, methyl paraben, propyl paraben, diazolidinyl urea, calcium benzoate, calcium propionate, caprylyl glycol, biguanide derivatives, phenoxyethanol, captan, chlorhexidine diacetate, chlorhexidine digluconate, chlorhexidine dihydrochloride, chloroacetamide, chlorobutanol, p-chloro-m-cresol, chlorophene, chlorothymol, chloroxylenol, m-cresol, o-cresol, DEDM Hydantoin, DEDM Hydantoin dilaurate, dehydroacetic acid, diazolidinyl urea, dibromopropamidine diisethionate, DMDM Hydantoin, and the like. In one preferred embodiment the composition is free of parabens.


F. Vitamins and Antioxidants


The compositions of the invention, may contain vitamins and/or coenzymes, as well as antioxidants. If so, 0.001-10%, preferably 0.01-8%, more preferably 0.05-5% by weight of the total composition are suggested. Suitable vitamins include ascorbic acid and derivatives thereof, the B vitamins such as thiamine, riboflavin, pyridoxin, and so on, as well as coenzymes such as thiamine pyrophoshate, flavin adenin dinucleotide, folic acid, pyridoxal phosphate, tetrahydrofolic acid, and so on. Also Vitamin A and derivatives thereof are suitable. Examples are Vitamin A palmitate, acetate, or other esters thereof, as well as Vitamin A in the form of beta carotene. Also suitable is Vitamin E and derivatives thereof such as Vitamin E acetate, nicotinate, or other esters thereof. In addition, Vitamins D and K are suitable.


Suitable antioxidants are ingredients which assist in preventing or retarding spoilage. Examples of antioxidants suitable for use in the compositions of the invention are potassium sulfite, sodium bisulfite, sodium erythrobate, sodium metabisulfite, sodium sulfite, propyl gallate, cysteine hydrochloride, butylated hydroxytoluene, butylated hydroxyanisole, and so on.


G. Film Formers


It may be desirable to include one or more film forming ingredients in the cosmetic compositions of the invention. Suitable film formers are ingredients that contribute to formation of a film on the keratinous surface. In some cases the film formers may provide films that provide long wearing or transfer resistant properties such that the cosmetic applied to the keratinous surface will remain for periods of time ranging from 3 to 16 hours. If present, such film formers may range from about 0.01 to 50%, preferably from about 0.1 to 40%, more preferably from about 0.5 to 35% by weight of the total composition. The film formers are most often found in the polymeric form and may be natural or synthetic polymers. If synthetic, silicone polymers, organic polymers or copolymers of silicones and organic groups may be acceptable.


1. Silicone Resins


One particularly suitable type of silicone film former is a silicone resin. Silicone resins are generally highly crosslinked structures comprising combinations of M, D, T, and Q units. The term “M” means a monofunctional siloxy unit having the general formula:

[Si—(CH3)3—O]0.5

In cases where the M unit is other than methyl (such as ethyl, propyl, ethoxy, etc.) the M unit may have a prime after it, e.g. M′.


The term “D” means a difunctional siloxy unit having the general formula:

[Si—(CH3)2—O]1.0

The difunctional unit may be substituted with alkyl groups other than methyl, such as ethyl, propyl, alkylene glycol, and the like, in which case the D unit may be referred to as D′, with the prime indicating a substitution.


The term “T” means a trifunctional siloxy unit having the general formula:

[Si—(CH3)—O]1.5

The trifunctional unit may be substituted with substituents other than methyl, in which case it may be referred to as T′.


The term “Q” refers to a quadrifunctional siloxy unit having the general formula:

[Si—O—]2.0


The silicone resins that may be used as film formers in the compositions of the invention preferably comprise highly crosslinked combinations of M, T, and Q units. Examples of such resins include trimethylsiloxysilicate which can be purchased from Dow Corning Corporation as 749 Fluid, or from GE Silicones under the SR-1000 tradename. Also suitable is a silicone resin that contains a large percentage of T groups, such as MK resin sold by Wacker-Chemie, having the CTFA name polymethylsilsesquioxane.


2. Copolymers of Silicone and Organic Monomers


Also suitable for use as the film formers are copolymers of silicone and organic monomers such as acrylates, methacrylates, and the like. Examples of such suitable film forming polymers include those commonly referred to as silicone acrylate or vinyl silicone copolymers, such as those sold by 3M under the brand name “Silicone Plus” polymers such as SA-70, having the CTFA name Polysilicone-7 and is a copolymer of isobutylmethacrylate and n-butyl endblocked polydimethylsiloxane propyl methacrylate; or VS-70 having the CTFA name Polysilicone-6, which is a copolymer of dimethylsiloxane and methyl-3 mercaptopropyl siloxane reacted with isobutyl methacrylate; or VS-80, having the CTFA name Polysilicone-8, which has the general structure:




embedded image



Where R represents the acrylates copolymer radical.


3. Organic Polymers


Also suitable as film formers include various types of organic polymers such as polymers formed from acrylic acid, methacrylic acid, or their simple C1-10 carboxylic acid esters, such as methyl methacrylate, methyl acrylate, and the like.


4. Natural Polymers


Also suitable are various types of natural polymers such as shellac, natural resins, chitin, and the like.


V. The Cosmetic Compositions


The anhydrous cosmetic compositions of the invention may be found in the form of anhydrous emulsions, serums, or gels; or color cosmetic products such as mascara, blush, lipstick, eyeshadow, eyeliner, brow color, an the like. The resveratrol derivative may be found in the oil phase. If the composition is found in the form of an anhydrous emulsion, the resveratrol derivative may also be dispersed or solubilized in the nonaqueous polar solvent phase of the anhydrous emulsion. For example, certain hydrophilic derivatives such as resveratrol triphosphate, resveratrol trisulfonate, and the like are generally hydrophilic in nature, and will better disperse or solubilize in the nonaqueous polar solvent phase of an anhydrous emulsion. On the other hand, such hydrophilic derivatives may also be dispersed in an anhydrous composition in the oil phase, in some cases with the use of amphiphilic materials. Certain other resveratrol derivatives are lipophilic in nature and can be easily dispersed or solublilized in the oil phase of the anhydrous composition, if desired.


Typical color cosmetic compositions such as foundations, blush, eyeshadow and the like will preferably contain from about 1-85% oil, from about 1 to 90% structuring agent, and from 0.1 to 65% of particulates that are pigments or a combination of pigments and powders. Optionally, the compositions may comprise from about 0.1 to 25% surfactant.


Typical anhydrous lash or brow color compositions contain from about 1-98% oil, 1-85% structuring agent, and from about 0.1 to 85% particulates.


Typical anhydrous emulsion compositions of the invention comprise from about 0.1 to 75% of a nonaqueous polar solvent, 0.1 to 50% structuring agent. They may be found in the form of serums, gels, or creams.


The invention will be further described in connection with the following examples which are set forth for the purposes of illustration only.


EXAMPLE 1

Anhydrous emulsion skin treatment serums and gels were prepared as follows:















w/w %










Ingredient
A
B
C














Pinus pinaster bark extract

0.50





Santalum album (sandalwood)



6.00


extract/phellodendron amurense bark extract


Calcium carbonate/zea mays (corn)
0.5


starch/glycine soja (soybean) extract


Lauroyl lysine


8.00


Butylene glycol
7.00
7.00
2.00


Ferulic acid
0.10


Glycerin
10.00
10.00


PEG-8


1.00


Polysorbate-80


0.50


Dicarylyl carbonate


22.00


PEG-60 hydrogenated castor oil


1.00



Simmondsia chinensis (jojoba) seed oil



21.50


Isopropyl isostearate


5.00


Isononyl isononanoate/ethylhexyl


17.00


isononanoate


Dextrin palmitate


7.00


Glyceryl behenate/eicosadioate


0.50


Hinokitiol
0.10


PEG-10 dimethicone
2.00
2.00


Dimethicone/caprylyl methicone/phenyl

65.00


methicone


Silica


7.50


Nordihydroguaiaretic acid
0.50



Camellia sinensis (green tea) extract

2.00


Phenoxyethanol
0.20
0.20
0.50


Trisodium resveratrol phosphate
0.50
0.50
0.50


Cyclomethicone/dimethicone/C30-45
2.00


olefin/phenyl methicone


Methyl trimethicone
3.00
3.00



Citrus grandis (grapefruit) peel extract

0.20


Dimethicone/vinyl dimethicone cross
71.40
75.30


polymer/methyl trimethicone









The compositions were prepared by combining the resveratrol triphosphate and glycerin. The remaining ingredients were combined and mixed well, followed by addition of the resveratrol triphosphate in glycerin.


EXAMPLE 2

A foundation makeup was prepared as follows:
















Ingredient
w/w %



















Cetyl PEG/PPG-10/1 dimethicone/polyglyceryl-4
1.00



isostearate/hexyl laurate



Red iron oxide/methicone
0.60



Yellow iron oxide
1.47



Dimethicone crosspolymer-3/isododecane
22.00



Polyethylene
4.00



Mica
10.37



Trifluoromethyl C1-4 alkyl dimethicone/
6.00



cyclomehticone/propylene carbonate



Titanium dioxide/methicone
6.80



Silica
0.001



Resveratrol tripalmitate
0.50



Cyclopentasiloxane
QS



Phenyl trimethicone
3.80



Dimethicone gum
0.20



Cyclomethicone/dimethicone/phenyl methicone
28.10



Mica/methyl methacrylate crosspolymer
1.00



Iron oxides/methicone
0.20



Titanium dioxide/iron oxides
0.01



Acrylates copolymer/diphenyl carbomethoxy
0.02



acetoxy naphthopyran



Titanium dioxide/trimyristin/hydrogenated lecithin
3.50










The composition was prepared by grinding the pigments in a portion of the oil. The remaining ingredient were combined with heat and mixed well, incorporating the pigment grind into the composition. The composition was a semi-solid beige colored composition suitable for use as a foundation.


EXAMPLE 3

A lipstick composition was prepared as follows:
















Ingredient
w/w %




















Aloe barbadensis extract/mineral oil

0.50



Trimethylsiloxypheny dimethicone (PDM 1000)
1.00



Octyldodecyl stearoyl stearate
3.05



Ceresin wax
6.50



Petrolatum
32.05



Hydrogenated vegetable oils
14.00



Polybutene
0.25



Ozokerite
16.25



Ethylhexyl methoxycinnamate
7.50



Propyl paraben
0.15



Phenyl trimethicone
1.00



Bis-diglyceryl polyacyladipate
2.50



Resveratrol triisostearate
1.00



Cetyl esters
QS



Ethylhexyl salicylate
3.50



Tocopheryl acetate
0.25










The composition was prepared by grinding the pigments in a portion of the cetyl esters. The waxes and oils were separately combined with heat and mixed well. The pigment grind was added to the mixture and stirred well. The mixture was poured into molds and allowed to cool to room temperature.


EXAMPLE 4

Powder eyeshadow and blush compositions were prepared as follows















w/w %









Ingredient
Shadow
Blush












Aluminum hydroxide
0.003



Sorbitan sesquioleate
0.001


Ascorbyl palmitate
0.04


Barium sulfate
0.0005


Soybean extract
2.47


BHT
0.70
0.05


Lecithin

0.0004


Candelilla wax
5.85


Carnauba
1.76


Castor seed oil
QS


Polyglyceryl-3 beeswax
3.23


Simethicone

0.05


Dipentaerythrityl hexahydroxystearate
2.50


Isodecyl neopentanoate
0.05


Caprylic/capric triglycerides
9.90


Mica
4.75


Oleyl oleate
6.70


Octyl palmitate

7.00


Polybutene

QS


Hydrogenated polyisobutene

30.13


Dextrin palmitate

11.00


Ozokerite
2.35


Synthetic wax
4.95


Diisostearyl malate
8.70


Bis-diglyceryl polyacyladipate-2
1.47


Polydecene
2.10
0.35


Mica/titanium dioxide

0.80


Propyl paraben

0.10


Titanium dioxide
3.10


Tocopheryl acetate
0.04


Iron oxides
5.11


FD&C blue no. 1 aluminum lake
0.10
0.002


D&C Red No. 6

0.01


D&C Red No. 7 Calcium Lake
0.36
0.25


Fragrance

0.50


3,5,4′-triferulate stilbene
0.80


3,5-dimethoxy-4′-hydroxystilbene (Pterostilbene)

0.50









The compositions were prepared by grinding the pigments in a portion of the oil. Separately, the oils and waxes were combined with heat and mixed well. The pigment grind was added. The compositions were pressed into pans.


While the invention has been described in connection with the preferred embodiment, it is not intended to limit the scope of the invention to the particular form set forth but, on the contrary, it is intended to cover such alternatives, modifications, and equivalents as may be included within the spirit and scope of the invention as defined by the appended claims.

Claims
  • 1. An anhydrous color cosmetic composition comprising at least one resveratrol derivative selected from the group consisting of: 3-ferulate-5,4′-dihydroxystilbene;5-ferulate-3,4′-dihydroxystilbene;4′-ferulate-3,5-dihydroxystilbene;3,5-diferulate-4′-hydroxystilbene;3,4′-diferulate-5-hydroxystilbene;4′,5-diferulate-3-hydroxystilbene;3,5,4′-triferulate stilbene;and mixtures thereof; and particulates.
  • 2. The composition of claim 1 further comprising an oil phase.
  • 3. The composition of claim 2 wherein the resveratrol derivative is dispersed or solubilized in the oil phase.
  • 4. The composition of claim 1 wherein the particulates are a mixture of pigments and powders.
  • 5. The composition of claim 4 further comprising at least one oil phase structuring agent.
  • 6. The composition of claim 5 wherein the oil phase structuring agent is a silicone elastomer, silicone gum, silicone wax, organic wax, montmorillonite mineral, or mixtures thereof.
  • 7. The composition of claim 1 which is a lipstick further comprising at least one nonvolatile oil, and at least one oil phase structuring agent.
  • 8. The composition of claim 1 which is a transfer resistant lipstick comprising at least one volatile oil, and at least one oil phase structuring agent.
  • 9. The composition of claim 1 which is in the form of a pressed or loose powder.
  • 10. The composition of claim 9 which is face powder, eyeshadow, blush, or lip color.
  • 11. The composition of claim 10 which is a face powder.
  • 12. The composition of claim 1 which is an anhydrous emulsion containing at least one non-aqueous polar solvent.
  • 13. The composition of claim 11 wherein the resveratrol derivative is solubilized or dispersed in the non-aqueous polar solvent.
  • 14. The composition of claim 12 wherein the nonaqueous polar solvent is ethanol, an alkylene glycol, or mixtures thereof.
  • 15. The composition of claim 14 wherein the anhydrous emulsion is in the form of a skin gel or serum.
  • 16. The composition of claim 7 wherein the nonvolatile oil comprises a silicone oil or an ester.
  • 17. The composition of claim 8 wherein the volatile oil comprises a volatile silicone, a volatile paraffinic hydrocarbon, or mixtures thereof.
  • 18. The composition of claim 17 wherein the oil phase structuring agent is an organic wax.
  • 19. The composition of claim 1 further comprising an oil phase structuring agent which is a non-emulsifying silicone elastomer.
  • 20. The composition of claim 1 further comprising at least one film forming polymer.
Parent Case Info

This application claims priority from provisional U.S. patent application Ser. No. 60/952,884, filed Jul. 31, 2007.

US Referenced Citations (79)
Number Name Date Kind
3215724 Strobel et al. Nov 1965 A
3439088 Edman Apr 1969 A
3781417 Welters et al. Dec 1973 A
3818105 Coopersmith et al. Jun 1974 A
4003966 Napier et al. Jan 1977 A
4677152 Allen et al. Jun 1987 A
4702844 Flesher et al. Oct 1987 A
4803067 Brunetta et al. Feb 1989 A
4970252 Sakuta et al. Nov 1990 A
5118496 Herstein Jun 1992 A
5183588 Salerno et al. Feb 1993 A
5183589 Brunetta et al. Feb 1993 A
5236986 Sakuta Aug 1993 A
5412004 Tachibana et al. May 1995 A
5549281 Hall Aug 1996 A
5654362 Schulz, Jr. et al. Aug 1997 A
5736161 Garces et al. Apr 1998 A
5760116 Kilgour et al. Jun 1998 A
5808119 Nkiliza Sep 1998 A
5811487 Schulz, Jr. et al. Sep 1998 A
5824326 Crotty et al. Oct 1998 A
5837793 Harashima et al. Nov 1998 A
5843193 Hawkins et al. Dec 1998 A
5916543 Kaplan Jun 1999 A
6147121 Breton et al. Nov 2000 A
6270780 Carson et al. Aug 2001 B1
6358517 Pillai et al. Mar 2002 B1
6407142 Courbriere et al. Jun 2002 B1
6440433 Breton et al. Aug 2002 B1
6465402 Lorant Oct 2002 B1
6497861 Wang et al. Dec 2002 B1
6524595 Perrier et al. Feb 2003 B1
6531132 Paufique Mar 2003 B1
6572882 Vercauteren et al. Jun 2003 B1
6573299 Petrus Jun 2003 B1
6610322 Keller et al. Aug 2003 B1
6872401 Seyler et al. Mar 2005 B2
6958160 Keller et al. Oct 2005 B1
6969531 Dehazya et al. Nov 2005 B2
6979440 Shefer et al. Dec 2005 B2
7026518 Gokaraju et al. Apr 2006 B2
7115282 Shefer et al. Oct 2006 B2
7150883 Keller et al. Dec 2006 B2
7714161 Andrus et al. May 2010 B2
20020051799 Pruche et al. May 2002 A1
20020183400 Baldo et al. Dec 2002 A1
20020197228 LaSala et al. Dec 2002 A1
20030124161 Biatry et al. Jul 2003 A1
20040009197 DeRosa et al. Jan 2004 A1
20040109894 Shefer et al. Jun 2004 A1
20040121019 Perrier et al. Jun 2004 A1
20040126337 Singleton Jul 2004 A1
20040209951 Gokaraju et al. Oct 2004 A1
20040254357 Zaloga et al. Dec 2004 A1
20050048008 Gupta Mar 2005 A1
20050106196 Cassin et al. May 2005 A1
20050118218 Cassin Jun 2005 A1
20050142079 Garrison et al. Jun 2005 A1
20050147631 Goldstein et al. Jul 2005 A1
20050220733 Tsuzuki et al. Oct 2005 A1
20060018869 Stab et al. Jan 2006 A1
20060210513 Luizzi et al. Sep 2006 A1
20070009455 Kim et al. Jan 2007 A1
20070015840 Dalko et al. Jan 2007 A1
20070110731 Riley May 2007 A1
20070160550 Charles nee Newsham et al. Jul 2007 A1
20070166269 Cassin et al. Jul 2007 A1
20080044373 Ilekti et al. Feb 2008 A1
20080076833 Van Brussel Mar 2008 A1
20080095866 Declercq Apr 2008 A1
20090035236 Maes Feb 2009 A1
20090035237 Maes Feb 2009 A1
20090035240 Maes Feb 2009 A1
20090035242 Maes Feb 2009 A1
20090047309 Maes et al. Feb 2009 A1
20090068132 Bratescu Mar 2009 A1
20090215881 Delaire et al. Aug 2009 A1
20100215755 Bratescu Aug 2010 A1
20100216879 Maes Aug 2010 A1
Foreign Referenced Citations (19)
Number Date Country
19638534 Mar 1998 DE
0 980 235 May 2003 EP
1634576 Mar 2006 EP
1640041 Mar 2006 EP
2862533 May 2005 FR
2867977 Sep 2005 FR
61-018708 Jan 1986 JP
6-118708 Apr 1994 JP
2002-080372 Mar 2002 JP
2004-532790 Oct 2004 JP
WO9904747 Feb 1999 WO
WO0130336 May 2001 WO
WO 0191695 Dec 2001 WO
WO2004024798 Mar 2004 WO
WO 2005069998 Aug 2005 WO
WO2006029483 Mar 2006 WO
WO2006029484 Mar 2006 WO
WO2006078941 Jul 2006 WO
WO2006134282 Dec 2006 WO
Related Publications (1)
Number Date Country
20090035243 A1 Feb 2009 US
Provisional Applications (1)
Number Date Country
60952884 Jul 2007 US